10,000 Matching Annotations
  1. Last 7 days
    1. On 2023-11-17 10:21:46, user EML wrote:

      Really interesting paper, will dive into this deeper. Quick comment and question already:<br /> - would it be possible to do segregation testing in pedigree 1? As the affected individuals are still alive it might be possible to obtain DNA (no large amounts needed).<br /> - It would be helpful if the pedigrees in figure 6 would be redrawn in such a way that the first generation does not appear to have offspring of two females...<br /> best wishes,<br /> Elisabeth Lodder

    1. On 2023-11-16 14:40:43, user disqus_46DQBV9D4A wrote:

      Dear Wenderson,

      thank you very much for the thorough feedback on our manuscript. We are very happy that you enjoyed the read! I think the preprint club in your lab is a great initiative!

      As our manuscript was under review and ultimately accepted in the meantime (https://rdcu.be/drgAc), we did not manage to address all the issues you mentioned for the peer-reviewed version.

      With respect to PC vs NMDS: we have adopted the method of doing both analysis since PC plots are limited to two variables in each iteration and this can cause statistical limitations with smaller sample sizes (as is the case here). NMDS collapses the variability to two dimensions and does not assume normal distribution. We use these two analyses in a complementary manner (one does not influence the outcome of the other, they are two independent methods). As our interest here was limited to inspect if the data is powerful enough to distinguish expression patterns at the respective time points, we did not focus on further discussion of these tests.

      With respect to identifying secreted proteins, we used SignalP5 and TMHMM to identify candidate secreted soluble proteins. This was only mentioned int he methods section and we could have added this in the results section, as well.

      We used the pipeline detailed in Figure 4 to identify the transcripts as noncoding. The tool CPC with a cutoff of an ORF length of 200 bp was used for that.

      Once again, thank you for your feedback!<br /> Best regards,<br /> Stefan Kusch

    1. On 2023-11-15 22:37:54, user Maxence Nachury wrote:

      Just saw the paper in my Pubmed feed a few days ago and decided to present it in my journal club today. Superb imaging throughout. The evidence for 2 mechanistically distinct regimes of PC2-EV release is persuasive.<br /> Minor point: I was less convinced by the evidence of ciliary localization of the ∆4-desaturase. The signals are very weak in cilia. A few more images with increased contrast would help. The images in 4C and the counting in 4D suggest that the enzyme is required for both regimes. Could the differences I eyeballed com to significance when more data points are included? <br /> The major point has to do with the interpretation that the contact between the worm and bare glass generates a mechanical perturbation. If neither clear nor dense core vesicles are required for glass exposure to trigger PC2-EV release form the tip, then we could only see two surviving hypothesis: HYP1- the PC2-EV releasing cilia are intrinsically mechanosensitive. Can one tickle the worms with a non-glass micromanipulator? HYP2- the borosilicate surface triggers a physical response upon contact. Can one use plastic coverslips to squeeze the worms?

    1. On 2023-11-14 21:36:11, user Sahar Melamed wrote:

      Please note that the figures are incorrectly displayed in the preprint (some technical issue on BioRxiv). Please refer to the published version for the updated version and correct display of the figures.

    1. On 2023-11-14 16:49:20, user James Mallet wrote:

      Congratulations on this provocative paper which I read with great interest.

      However, I have some questions about the meaning of the results. Your paper suggests that previously, the prevailing belief has been that there is more hybridization, and therefore more gene flow between species, in plants than in animals. However, your preliminary discussion suggests that this is actually an artefact of “rely[ing] on morphological traits to arbitrarily define species (16),” where ref. 16 is Mallet 2005 in TREE. Although it is true that the data summarized in Mallet 2005 was indeed based largely on morphologically identified species (and their hybrids), it doesn’t rely on a morphological species concept. Anyone who knows taxonomy of any group of organisms knows also that morphology is a rather good, although not foolproof, guide to species status; two sister species, when they co-occur in sympatry, will typically display two modes in multivariate morphospace. Actually, Mallet in 1995 and 2005 argues for a genotypic cluster definition of species, which certainly applies to molecular markers as well as morphology. Two related species, if they co-occur in sympatry, will display a series of genetic differences that enables them to be identified, even if they hybridize. There are two modes in the multivariate genotypic distribution; the relationship with the classical taxonomist’s morphological identification of species is clear.

      Then you argue “the emergence of molecular data ... enables substituting the human-made species concept with genetic clusters that quantitatively vary in their level of genetic distance (18),” where ref. 18 is Galtier 2019 in Evolutionary Applications. Now that is interesting, as I think Galtier proposes “Species are defined as entities sufficiently diverged such that gene flow (arrows) is very rare or inexistent” (his Fig. 1). In other words, he appears to have a species concept such that gene flow between species is zero. Any gene flow, he argues, would render the situation “ambiguous”.

      Later, perhaps recognizing that this is too extreme, Galtier proposes using a reference species based system: “...to identify taxa in which large amounts of data are available, and species boundaries are consensual, or can be agreed on. Species delineation in any other taxon could thus be achieved so as to maximize consistency with the reference [taxa].”

      Now perhaps this dickering about what is a species appears rather unreasonable, since I think we all know (and Nicolas Galtier certainly seems to agree) that there is a continuum between populations that are not species and those that are species. However, in order to disprove the prevailing narrative that plant species hybridize more than animal species, you really must take a stance on what you mean by a species, and what you mean by a population that is not a species. My natural history knowledge of flowering plants and animals such as insects and birds suggests that plant species that co-occur in sympatry really do have a higher rate of hybridization than animal species. Not only is a greater fraction of species involved, but when they do hybridize, there are usually a lot more hybrids.

      But you will say perhaps: “that is not really the question we attempt to answer.” And indeed it is not, so perhaps you should not have complained that that finding about whether species hybridize was an artefact, which you appear to do.

      The question you more attempt, I think, to answer is: “is introgression more common in plants than in animals for a given level of genetic divergence, DA?” Rather than a question about species, it seems to me you are asking a question here that is independent of what your (or the reader’s species) concept is (unless you argue that a species has a certain threshold level of genetic divergence).

      After arguing that “the Tree of Life” is “interrupted by species barriers that are progressively established in their genome as the divergence between evolutionary lineages increases,” you then argue that “The consequences of reproductive isolation can therefore be captured through the long-term effect of barriers on reducing introgressing introgression locally in the genomes, which provides a useful quantitative metric applicable to any organism (4).”

      Ref. 4 is Westram et al. (2022) J. Evol. Biol. “What is reproductive isolation?” Westram show that it’s actually very hard to measure overall reproductive isolation, RI, which they say is determined by the level of “effective migration” at neutral loci, or the fraction of the rate of neutral genes that actually establish (reduced due to species barriers) in the recipient population, me, divided by the rate of “potential gene flow,” m, into the population caused by the potential for hybridization and backcrossing, or RI = 1 - me/m. Effective gene flow depends on where in the genome you measure it; in which direction you measure gene flow; whether populations are parapatric or sympatric; whether you want to measure it using an “organismal” or “genetic” focus (in Westram et al.’s terminology). Furthermore, it depends on who is measuring it and how. Everyone who measures it seems to have somewhat different measures of reproductive isolation (Sobel, J. M., & Chen, G. F. (2014). Unification of methods for estimating the strength of reproductive isolation. Evolution, 68, 1511–1522). It doesn’t provide a very useful comparative measure applicable at the whole species level at all. My colleague from Boston University and I conclude from perusing the lengthy discussions in Sobel & Chen and Westram et al. that measuring overall reproductive isolation is unlikely to be useful, and we would be better off just accepting that it is a vague heuristic which expresses something about species (Mallet, J., & Mullen, S.P. 2022. J. Evol. Biol. 35:1175-1182). In contrast, one can readily measure some of its many components, such as “hybrid inviability”, “assortative mating” and so on, and these remain useful and interesting at the whole species level and as comparative indicators.

      Again, it may seem a distraction that I am discussing what is reproductive isolation, but it seems important here, because you are using a measure of reproductive isolation, and then relating it to genetic distance. In Westram et al., the main concern was to develop an experimental measure of reproductive isolation. Westram et al cautioned against estimating reproductive isolation from sequence data, which is the method you employ here. Their reasoning is that sequence divergence is a consequence only of actual gene flow, me (after taking into account barriers to gene flow), and that there is no way of estimating “potential gene flow” from the same data. In the main part of the paper (e.g. the data points in Fig. 1A), there seems to be a non-continuous measure of reproductive isolation, such that “migration” has a value 1, whereas “isolation” has a value zero. It was not entirely clear to me why this should be so, since, whatever it is, it seems clear to me that reproductive isolation should surely be a continuous parameter. Delving into the supplement, I found that “genetic isolation” was indicated “when our ABC framework yields a posterior probability P(migration) < 0.1304. This threshold was empirically determined by the robustness test conducted in (Ref. 6).” Similarly, the same robustness test yielded “strong statistical support for ongoing migration ... when the posterior probability P(migration) > 0.6419.” Pairs of taxa with intermediate posterior probabilities were considered “ambiguous” and were discarded. Note that P(migration) is not the actual mixing rate of the populations, me, or the fraction of the genome exchanged, but, if I understand it correctly, the posterior probability that any gene flow at all occurs. This is a very different measure of reproductive isolation from that proposed by Sobel et al. or Westram et al., or anyone else.

      I think the reason for your choice of a measure of reproductive isolation is indicated by the second question you ask in the introduction: “At what level of molecular divergence do species become fully isolated?” This is related to a common conception of species as irreversibly independent lineages, and the idea that speciation will be “complete” when gene flow becomes zero. But in fact, the “completion” of speciation in this sense seems rather unlikely. The progressive loss of compatibility between diverging lineages seems likely to follow some sort of continuous probabilistic failure law, similar to the way lightbulbs fail over time. The simplest failure law is log-linear with time, although more complex models such as the accelerating “snowball” model of hybrid incompatibility, or the likely “slowdown” model for selective reinforcement, are also possible (Gourbière, S., & Mallet, J. 2010. Are species real? The shape of the species boundary with exponential failure, reinforcement, and the "missing snowball". Evolution 64:1-24); but all have a long asymptotic tail. You seem to recognize this stretched out right-hand side timescale by plotting genetic divergence on a log scale in Fig. 1 (although why is “net divergence,” Nei’s DA, the correct scale on which to base such an analysis? You do not explain or justify this). Nonetheless, by making an argument for complete isolation as an endpoint, you ignore the asymptotic nature of compatibility decline to zero. Based on the data we analyzed, it is rather hard to estimate the shape of the failure curve, mainly because the accumulation of incompatibilities is so variable, even among closely related species, such as Drosophila fruit-flies, for example. This variability between pairs of species shows up only in the data, and not in the fitted curve in Fig. 1A, but is more evident from Fig. 1B.

      Overall, I remain somewhat unconvinced that plants have a more rapid accumulation of species barriers than animals. I agree it is likely that many plants have “less efficient dispersal modalities” than most mobile animals, and that this might mean that actual gene flow becomes lower for plants at a distance from one another, but this is a little different from what I think one would mean by “species barriers.” Reproductive isolation and species barriers should generally be rather independent of geography; in other words reproductive isolation at close range is what we are primarily interested in. This is the problem of using a measure of reproductive isolation that depends purely on actual gene flow. I therefore remain unconvinced that my natural history observations of many plant hybrids in nature, and very few animal hybrids, are not reliable indicators of lower levels of reproductive isolation among plants than among animal species.

    1. On 2023-11-14 09:58:04, user Thomas McCorvie wrote:

      The authors should be aware that their FSC curves for two of CtRoco-NbRoco1-NbRoco2 maps indicate duplicate particles. This is shown by the FSC curves not dropping below a value of zero.These can easily be removed using the Remove Duplicate Particles in CryoSPARC. Testing different Minimum separation distance (A) values is recommended.

    1. On 2023-11-14 05:33:52, user HILA GELFER wrote:

      I found the topic of your research incredibly fascinating and important as scientists try to better understand how to prevent cancer relapse among patients. Understanding the role of TAMs in preserving OvCSC presence serves an important purpose in identifying how to improve treatment responses to cancer patients. Here are some general comments I had on the statistics and figures in your paper.

      1. Within Figure 3 (ex: 3B) you utilized medians as markers within your data, while earlier data utilized means. While both are proper statistical measures, the inconsistency in how the data is represented may be a little confusing for the readers. To improve coherence in their data, I would utilize either medians or means throughout the whole paper. Additionally, medians sometimes fail to note any skewness in the data. I think to further improve the representation of the data it may be a good idea to perform a Shapiro-Wilk test to determine the normality of the data.
      2. Within several figures, including 3F, there were very few samples within each treatment group. Since no power analyses were performed, it may be difficult to determine the true statistical significance of the data. To improve confidence in your findings, I would recommend performing power analyses and adding more samples/replicates in future research to further increase confidence in your data as necessary.
      3. Figure 1E indicates the percent survival of different cultured cells receiving different doses of treatments. Despite different cultures receiving different treatment doses, the points on the graph were connected making it difficult to decipher the differences between the samples. To increase clarity in the data, I would represent the data in the form of a bar graph or other similar form to better distinguish the differences between the samples.

      Overall, I found your paper incredibly fascinating and hope to see further research on the topic to improve patient care!

    1. On 2023-11-14 04:00:34, user JK Gamja wrote:

      We represent our research about active microbial metabolite PLA produced by lactic acid bacterial. I hope this study help readers to provide the reason and mechanism of beneficial effects of probiotics.

    1. On 2023-11-13 10:43:48, user Gary Mirams wrote:

      This is a very nice use of a mathematical model of patch clamp compensations to account for artefacts in fast sodium recordings at 37C.

      Just a little note that whilst Lei et al. (2020) introduced the artefact model without supercharging/prediction compensation, we expanded on that to include those effects in the artefact model version published in Chon Lok Lei's thesis: https://chonlei.github.io/t...

    1. On 2023-11-12 00:05:45, user Elizabeth Duncan wrote:

      Recently, a group of trainees read and discussed this preprint as part of a journal club at the Markey Cancer Center at the University of Kentucky. We thought the findings suggesting that SETD1A may be driving the increase in H3K4me3 in MLL1 mutated cells (and possibly leukemic cells with MLL1 translocations) were very intriguing. However, we have several questions and suggestions:

      In figure 2B (metagene analysis) and C (pie charts), you plot the mean read counts from H3K4me3 ChIP-seq. We interpret the unexpected lack of enrichment of H3K4me3 at gene TSSs in the WT sample as a reflection of the relatively significant increase of H3K4me3 at new gene loci in the MT1 and MT2 cell lines. Is this correct?<br /> If so, we believe this point could be made stronger by adding, for example, a Venn diagram of the genes with MAC2 peaks in the WT cells and those with peaks in the MT1 and MT2 cells. You could also create two separate metagene plots based on the data in Figure 2B: one looking at H3K4me3 in all three cells lines at genes with MACS2 peaks in WT, and one looking at H3K4me3 at genes with MACS2 peaks in MT1+MT2.<br /> Given that there is likely variability in the chromatin state in different iPSC lines, we also wonder if you performed these experiments and/or analyses using a separate iPSC line?<br /> It is unclear how you performed the differential expression analyses in figures 3, 4, and 5. The heatmaps show changes in both the WT and the mutated cell lines, even though we assume the differential expression is in relation to the WT cells? We appreciate there are many ways to perform these analyses, however we would like to understand the details of how they were done here to better understand their implications.<br /> What happens if you knock down SETD1 expression in the MLL1-R3765A cells?<br /> Do you see the same effects if you KO or KD MLL1? Versus this mutation that prevent association with WRAD?

      We look forward to seeing your paper in publication.

    1. On 2023-11-10 23:23:41, user Hui Wang wrote:

      The study suffers from two serious flaws that undermine its credibility:

      1. The authors overlook the fact that the aromatic ring of tyrosine 90 is essential for the SH3 domain hydrophobic pocket structure. They incorrectly present the Src90E mutation as mimicking phosphorylated tyrosine, ignoring the expected disruptive effect of almost any mutation at this site. This flaw raises doubts about the validity of their interpretation, as the observed data may be a result of the grossly disrupted SH3 domain binding site rather than of simulating Tyr90 phosphorylation.

      2. The study neglects the tightly regulated nature of Src kinase activity through phosphorylation by Csk. Previous research by Erpel et al. 1995 has demonstrated that the mutation of Tyr90 to alanine impairs the interaction with Csk and the negative regulation of Src kinase. As the mutations Src90E and Src90A are supposed to disrupt the SH3 domain binding pocket in essentially the same way, the authors fail to acknowledge this crucial aspect. This oversight undermines the study's reliability and suggests that the similarities observed between Src90E and Src527F may be solely due to the impaired interaction with Csk.

      These flaws significantly impact the study's findings and raise concerns about the thoroughness and accuracy of the authors' interpretation. Caution should be exercised when considering the conclusions presented in the study.

    1. On 2023-11-10 16:44:10, user KJ Benjamin wrote:

      Interesting approach, but I'm confused why the authors would model population instead of genetic ancestry? The authors use ADMIXTURE to show a great degree of mixed ancestry, but do not examine the effect of genetic ancestry, but "population grouping". This would be extremely influenced by environmental factors that are differences across and within continental groups.

    1. On 2023-11-10 00:14:27, user Alan Rose wrote:

      This is an impressive manuscript reporting a stunning amount of work that reveals an interesting and underappreciated feature of gene regulation in plants, namely that sequences downstream of the transcription start site (TSS) can have major roles in regulating expression. My only complaint is that it does not sufficiently cite previous work that reaches many of the same conclusions. Findings reported here that were previously published for Arabidopsis include the observation that sequences downstream of the TSS, in exons and introns, play a major role in controlling transcription (Rose and Gallegos, 2019, Scientific Reports 9:13777), that these sequences are unlike animal enhancers because they have no effect when moved upstream of the TSS (Rose, 2004, Plant Journal 40:744 and Gallegos and Rose, 2017, Plant Cell 29:843), that a motif containing the sequence GATC boosts expression in a dose-dependent manner and that mutating nucleotides within the GATC motif reduce its effect (Rose et al., 2016 Plant Molecular Biology 92:337). The Rose and Gallegos 2017 paper is cited but only as the reason for using the TRP1 promoter and for identifying the motif similar to GATC. I realize that the number of references is limited in some journals, especially those with a high profile (where I would really like to see this work published), but these seem too pertinent to omit.

    1. On 2023-11-09 17:10:12, user Reade wrote:

      The biological concepts of the paper are easy to understand and follow as one experiment leads to another. The toy figures at the beginning of the figures outlining the experimental overview are very useful. There are some grammatical errors in the paper for example “casual relationship” which should be causal. Which statistical test is being used is unclear and at times I believe the wrong statistical analysis is used. For example, figure 1 states that Wilcoxon test or one-way ANOVA is used for comparison, but nothing indicates which analysis is used for which figure. Furthermore, when doing relative expression it is unclear what the expression is compared to, some graphs indicate it is relative to IRPL13a, but it looks like this is not true as in figure 2F the MFN2+/+ HEY1 and ID3 are both set to 1, suggesting that is what is being compared. The labeling of figures also makes it difficult to identify what is being compared, again in figure 2F it is unclear what the p values are indicating as they are over more than two groups. There are a few figures that I would like to see controls to compare against the date, example in figure 3A and 4I.

    1. On 2023-11-09 15:17:53, user Bertram Klinger wrote:

      Thank you for the nice explanation of expectation maximisation.

      However, in my eyes your algorithm does not get rid of the spillover signal. <br /> In Fig3C the correlated distribution is the result of spillover from channel Yb172 into Yb173, as can be seen nicely in Fig3D where this correlation vanishes with the same antibody labeled to a channel which Yb172 does not spill into (Sm147D). Instead your algorithm seems to only set low signals to NA.

      To undermine this point, Fig1a shows that the spill-in signal from Yb172 into the Yb173 channel is on average 2.7. Assuming the the mean of Yb172 bead to be of similar strength as Yb173 (~6.2) then for a cell population without Yb173 we would expect a difference of roughly 3.5 (in log scale) between the two channels if purely driven by spillover. Which is what can be seen in Fig3C for the CD3-low population ( i.e. they do not express CD3).

    1. On 2023-11-09 00:17:42, user Pooja Asthana wrote:

      Summary:<br /> Identifying and modeling low occupancy structural changes and binding events is a major goal of protein crystallography. The most sensitive methods used to detect low occupancy changes require crystallographic datasets to be isomorphous, which often limits their applicability. To address this limitation, the authors have developed MatchMaps, an pipeline that performs map subtraction in real space rather than reciprocal space, thereby eliminating the need for isomorphous data. The MatchMaps approach takes measured structure factor amplitudes from two states: the ON state (the interesting/ligand-bound/perturbed state) and the OFF state (the ground/apo/unperturbed state). Next, the algorithm performs rigid body refinement of the OFF state model (e.g. a model built/refined using only the OFF state data) using both the ON and OFF structure factor amplitudes. The electron density maps are then aligned by a rotation-translation matrix derived from alignment of the ON and OFF refined models. The authors apply MatchMaps to four different cases studies and where applicable, compare the results with isomorphous difference maps

      We tested the MatchMaps algorithm with some published datasets of the SARS-CoV-2 NSP3 macrodomain with ligand bound at 10-30% occupancy (​​https://zenodo.org/records/..., ligand-bound datasets UCSF-P0628, UCSF-P2193, UCSF-P2227 and apo dataset UCSF-P0110) along with some unpublished data. The program is well documented and easy to install. With some generous help from the authors, we successfully used MatchMaps to reproduce ligand density observed in isomorphous difference maps calculated using the same datasets. The initial issue we encountered had to do with the default solvent mask, but this was overcome based on their advice. We also successfully ran matchmaps.ncs to calculate a difference map between the two macrodomain protomers in the P43 crystal form (chain A and B of apo dataset UCSF-P0110).

      Overall, the preprint is well written and the figures are clear and helpful. The major success of this work is the development of a method for the real-space subtraction of electron density maps to visualize structural changes between non-isomorphous datasets. This provides structural biologists with a powerful tool for visualizing structural differences between X-ray diffraction datasets and therefore will be of broad interest to the community. The major limitation is whether MatchMaps can be used to detect structural differences that are not detected using isomorphous difference maps, or to model structural differences that are not apparent by comparing refined coordinates. Although visualization is helpful, the real power in a tool such as this would be in its ability to detect and model low occupancy states.

      Major points<br /> The manuscript could be strengthened by including an example where MatchMaps detects a structural change that was not detected by calculating isomorphous difference maps or by comparing refined coordinates. The authors show how MatchMaps removes artifacts due to misaligned models (Figure 3g), but it is unclear to us whether MatchMaps can detect new structural changes. Put another way, it’s unclear to us whether structural changes that result in non-isomorphous datasets would be better visualized using MatchMaps versus a simple comparison of coordinates.<br /> MatchMaps produces two maps by default, one with a solvent mask applied and one without. We are curious why a map with a solvent mask is calculated. This mask is based on the OFF model, so any features of the difference map corresponding to structural changes outside of the solvent mask will be removed. If the solvent mask is required to remove noise in the MatchMaps generated maps, then it would be helpful to discuss this and give examples where the solvent mask was necessary (because this goes somewhat against the claim made by the authors that MatchMaps maps are less susceptible to “uninteresting signal” - line 215). The solvent masking also was a challenge for us in detecting some fragments, but was resolved by working through different options with the authors. An expanded discussion of the merits and limitations of solvent masking (and when to depart from defaults) is therefore likely to be helpful to many users.<br /> Do the authors envisage that MatchMaps could be used to model structural changes or just to visualize them? Along these lines, a comparison with the PanDDA algorithm might be helpful (Pearce, N. M. et al. 2017, Nature Communications). PanDDA can be used to both detect and model low occupancy states, but is most effective when data sets are isomorphous (so is typically used to detect and model low occupancy ligands obtained by soaking). Can the authors imagine an extension to MatchMaps where multiple datasets are averaged to create the OFF map in a similar way to PanDDA? Improving the signal-to-noise of the OFF map might remove the need for the solvent mask.

      Minor points<br /> Figure 3c/d. Can the authors comment on differences between the isomorphous difference map and the MatchMaps map? The density is similar but not identical. This is subjective, but to us the MatchMaps density looks a little noisier.<br /> Line 95. Are the data scaled with SCALEIT and then truncated (line 95)? Wouldn’t the reverse be more appropriate (e.g. truncation followed by scaling)?<br /> We were grateful for the -verbose flag in the command line, however, this only prints the output from SCALEIT/phenix.refine. Would it be possible to modify this flag to print the output from all the programs?<br /> Line 104. How are the maps placed on a common scale?<br /> Figure 2f. Is there positive difference density associated with the terminal ribose (or the unmodeled nicotinamide) in the MatchMaps? It would be helpful if the figure legend indicated what part of the model the maps are contoured around. <br /> Line 350. The text says ±2.5 σ but the figure says ±1.5 σ.<br /> Line 161-162 - figure references do not refer to the correct panels. <br /> Line 185-189 and fig. 4d label and text does not match- open:closed conformation/ H-bond

      Review by Pooja Asthana, Galen J. Correy & James S. Fraser (UCSF)

    1. On 2023-11-08 20:29:54, user P. Bryant Chase wrote:

      Molecular basis for the "Abbott effect"? Bud Abbott was thrilled to know it was still being investigated in the 1980's, and would surely be thrilled to see this work if he was still living.<br /> Abbott BC & Aubert XM. (1952). The force exerted by active striated muscle during and after change of length. J Physiol 117, 77-86.

    1. On 2023-11-07 13:19:53, user Pedro H. Oliveira wrote:

      This is a very interesting manuscript.<br /> It was a pity however to not have seen discussed in this work the recent findings on defense systems' co-localization published here (https://www.biorxiv.org/con.... I believe the latter work will also be useful to update a few of the claims mentioned by Wu et al. in their Introduction.

    1. On 2023-11-06 14:56:20, user jfritscher wrote:

      I question the practice to benchmark against a tool from 5+ years ago (MetaPhlAn2) that has massively improved in the meantime to demonstrate the own tool's performance. For the same reason I do not think the results in Fig 3 are in any way telling about the performance of MAGinator in the light of state-of-the-art tools. It is claimed that subspecies-level resolution is gained by using GTDB-tk. This is questionable has GTDB-tk resolves at species level and thus the increase in "resolution" is merely a result of using a different taxonomy and not because actual subspecies resolution (whatever that is anyway) is achieved. Further, I would not use "de novo identificiation" is this context.

    1. On 2023-11-06 12:55:04, user Faraz K. Mardakheh wrote:

      Congrats Mathias and the team. It is good to finally see this preprint out.

      For any interested readers, I should also mention our preprint describing a very similar method (named TREX) which came out a few months before, since it is not cited in your preprint:

      https://doi.org/10.1101/202...

    1. On 2023-11-06 10:32:22, user MoMo wrote:

      Hi,I like your work very much and wish you to publish the final version soon. I would like to point out that TP53 mutants may not be "unfunctional". Some missence point mutations (e.g. R175H, R273H) result in gain of function (GOF). You cited the paper by Escobar-Hoyos showing this. I also found that GOF mutant p53 regulate splicing of VEGFA, however the mechanism was different (Pruszko et al., 2017). It would be interesting to use your bioinformativ tools and skils to compare alternative splicing in GOF p53 mutants versus loss of function.

    1. On 2023-11-06 04:33:44, user Raghu Parthasarathy wrote:

      The title really needs "in rats" (i.e. "in Female and Male Rats"). Otherwise, it is at best unclear and at worst suggests very general experiments about male and female animals of all sorts.

    1. On 2023-11-06 00:38:13, user Sergio Contreras Liza wrote:

      In this research we try to demostrate the effect of microbes (bacteria) on the production of potato seed tubers. Azotobacter sp.and Bacillus sp. were the most important genus in the form of consortia, for tuber number and weight.

    1. On 2023-11-05 08:37:13, user Manuela Giovannetti wrote:

      Dear Olga and co-authors,<br /> I have just read your paper and I want to compliment for the high level of your study. Your data are very interesting and worth of depth consideration. I have only a doubt, concerning the retrieval of bacteria other than endobacteria in your spore. As you may know, we have retrieved many bacteria strictly associated with AMF spores (after 15 washings). Actually, you performed a de-contamination of spores, with H2O2 and chloramine T, so you assumed that the retrieved bacteria were endobacteria. As our previous works described the occurrence of bacteria within the different layers of spore walls, I wonder whether they may have been protected from de-contaminating agents in such a peculiar niche. This is why we defined them as "stricty associated". With all my best wishes and regards, Manuela Giovannetti

    1. On 2023-11-03 18:45:39, user Marouen Ben Guebila wrote:

      scTranslator bioRxiv public review

      Summary: Quackenbush lab journal club review of “A pre-trained large generative model for translating single-cell transcriptome to proteome by Liu et al., 2023.” This work is motivated by the lack of sc-proteomics data sets because they are limited by available sequencing technology. The paper presents a transformer-based model called sc-translator and employed 31 cancer data sets for training and validation. Training is based on a 2-stage process. Stage 1 is training on bulk (pre-training) and Stage 2 is training on sc data sets. The model is based on favor+ which is a transformer attention mechanism

      Pre-training: In the isoforms prediction example, it seems that isoforms are predictive of each other e.g. CD49a and CD49b and not through model precision towards each isoforms. Correlation seems to be driven by a small number of data in the plot (Upper right portion of the correlation plot). Also, application on new dataset other than PBMC is warranted here to assess generalizability. Immune response is harder to predict: rare immune cells

      The application on new data showed that pre-training is very important, however it is not clear why cosine is used and not correlation as an evaluation metric.

      Downstream tasks:<br /> - More benchmarks on the attention interaction network are needed. It would be great to see a few examples of which genes regulate which proteins and their biological interpretations.<br /> - Pseudo-KO experiments also need to be benchmarked. There are many CRISPR knockout datasets which can be used for validation. Biological interpretation is missing for these experiments.<br /> - It would be nice to have a conduct GSEA in KO experiments<br /> - Finally for cell clustering (Figure 5a), it is likely that batch effects in true proteins are subpopulations for CD4 and not driven by batch.

      Potential future use:<br /> - It would be nice to predict protein levels in a different setting such as drug response for example.<br /> - Conduct more benchmarks for KO experiments beyond EGFR and TP53

      Additional comments:<br /> - Lack of evaluation in a real-life setting without the presence of protein data that can be used to fine tune the model first<br /> - Would it be possible to build a model for each protein or protein class which seems to make more sense because post-translational modifications vary between proteins and therefore fitting a single model can overlook these differences.

    1. On 2023-11-03 15:51:53, user Corresponding Author wrote:

      We - the authors of this manuscript - appreciate a Community Review of this manuscript posted here: https://zenodo.org/records/.... We agree with the overall assessment of the reviewers.<br /> 1) For the method description, we have cited previous publications and mentioned ‘as described previously’. Based on the reviewers' suggestion we will further describe the methods in detail to clarify the reviewers' concerns. In addition, we will include the age and sexes of mice in the legends of each figure. We will upload a revised version of this manuscript in a few months. eLife journal will publish the manuscript.<br /> 2) We agree with the reviewers that additional experiments are necessary for in-depth analyses of how elevated glycosuria increases compensatory glucose production. The goal of this project was to provide a foundation for future studies that will be informed by the list of secreted proteins identified using plasma proteomics, some of them may be correlative and others causal. At this time, it is not feasible to test each of the identified protein for its causal role in enhancing a compensatory glucose production. <br /> 3) eLife will publish a revised version of this manuscript in a few weeks.

    1. On 2023-11-03 14:34:03, user Alex wrote:

      It is not clear about the background of the used mutants. Some lines have WS background (for example, ahk3-1 and ahk3-2 - Wisconsin University lines WS-2) [Nishimura et al., 2004], while others - Col-0. <br /> Authors, however, always used only Col-0 as a control. <br /> Please, provide the proper background description for every used line.

    1. On 2023-10-31 15:03:11, user Scott C Thomas wrote:

      For table 1, it looks like citation 17 used an Illumina HiSeq platform. "Libraries Preparation and Sequencing<br /> Libraries were prepared using the Nextera DNA Library Preparation kit (Illumina) and sequenced on an Illumina HiSeq platform (leading to 40,552,111 ±9,650,536 reads/sample)."

      Also, Qiagen is a company, not an extraction kit. Qiagen manufactures many of the kits listed in table 1, so it is confusing to have "Qiagen" listed as a DNA-Exk.

    1. On 2023-10-30 08:40:11, user Estel Collado Camps wrote:

      Dear authors,<br /> I've learned a lot from reading your pre-print! I'm intrigued to see what language models will mean for deeper understanding of complex biomedical data in the near future. <br /> I have noticed that a few UMAPs (see for example figures 3 and 4) have slightly different shapes in the differently colour-coded versions (a vs b, c vs d). As a non-expert, I can imagine that this can easily be missed while updating figures. I thought it would be beneficial to everyone to give a heads-up.

    1. On 2023-10-29 09:08:48, user BBB Prair wrote:

      Fascinating study as expected from the Yanai lab. I work on DTPs as well. I read the whole preprint and watched the Match Onco seminar by Prof. Yanai about this work. Maybe I missed some point in the paper but I wonder why the identified IC50 for drug-naive Kuramochi cell line is ~2 uM? In my own measurements, using both CellTiter-Glo and SRB assays in a 12-concentration range, 72-hr format, I always calculate an IC50 in the range of 150 to 200 uM in Kuramochi cell line for olaparib. These values are also supported by measurements in the GDSC (both versions 1 and 2) project. Did the authors check this? This might be an issue in the context of drug adaptability since the cell line, in bulk, is already poised to adapt by tolerating low uM olaparib concentrations used in the study (<160 uM).

    1. On 2023-10-27 23:34:09, user CDSL JHSPH wrote:

      Hello! I had a great time reading your paper as it is very important to the field of public health and very informative!

      I was wondering, however, if there was enough data that was collected to show the immune response differences in those who had the vaccines separately. I assume that the closer you get the vaccines together, the better your IgG responses will be in the future, but I'd be interested to see if there is a weird window of time that the second vaccine becomes a catalyst for a more powerful IgG response (something random like 9 days after the second vaccine perhaps?) .

      Again thank you so much for your effort that you put into this research as it is very important and helpful to so many!

    2. On 2023-10-24 08:15:41, user CDSL JHSPH wrote:

      Hello!

      I found this paper very compelling. Nice work! It is really exciting to see that receiving both vaccines concurrently enhances the protectiveness of the COVID-19 booster. I have two questions:

      1. Why is it that the group that received the two vaccines on different days were not administered the flu vaccine on the same number of days apart after the COVID vaccine? In the study it was stated that the flu shot just needed to be administered any time within 4 weeks from the time of the COVID booster. Could this have made the results more difficult to interpret? If you were to redo the study, do you think that the data would be more reliable if the second group all had the later flu shot administer on the same day, or does that not seem to matter?

      2. Why was the Ebola vaccine used as the control vaccine in this case?

      Thank you! And again, nice job!! :)

    3. On 2023-10-23 04:34:17, user CDSL JHSPH wrote:

      Greating Dr. Barouch and colleagues,

      First, I want to commend you on investigating this timely research question regarding the immunogenicity of concurrent versus separate COVID-19 and influenza vaccination.

      As I was reviewing your work, some aspects caught my attention which might further enhance its clarity and comprehensiveness. I understand that the study participants in MassCPR might have enrolled voluntarily. If this is the case, there could be potential selection bias to consider. It might be beneficial for readers to see a demographic table that provides baseline characteristics for both groups. Additionally, it would be helpful to understand the factors that influenced participants to either receive both vaccines simultaneously or at two separate intervals. Clarifying this could help readers discern if there might be any inherent differences between these two groups.

      It also would be enlightening if you could expand on the potential mechanisms of the specific immune interactions that may be driving the increased IgG1 with concurrent vaccination? This could reveal important biology behind your findings.

      I believe addressing these points could enhance the comprehensiveness of your paper. I hope these suggestions are helpful as you continue developing this research project.

      Thank you for sharing your work and for your consideration.

    4. On 2023-10-20 01:55:50, user CDSL JHSPH wrote:

      Hello! I hope this message finds you well. I would like to express my sincere appreciation for your paper. Your research on the immunogenicity of these vaccines, especially in the context of concurrent versus separate administration, is of significant importance in the current landscape of emerging COVID-19 strains. I have a couple of queries that I hope you could kindly address:

      1. Given that the influenza vaccine undergoes changes each year to adapt to evolving strains, I am curious about the potential impact of these changes on the observed results. Do you believe that the higher and more durable SARS-CoV-2 antibody responses associated with concurrent administration would remain consistent across different influenza seasons?

      2. It appears that your study design involves a comparison between concurrent and separate administration, and the results are promising. Could you kindly provide more information on the research methodology? Specifically, was your study a randomized controlled trial (RCT), and if so, was blinding or randomization implemented?

      Once again, I would like to express my gratitude for your valuable contribution to the field. I understand the dedication and effort that go into such research endeavors, and your work is commendable. I look forward to any insights you can provide regarding my queries.<br /> Thank you for your time, and I appreciate your consideration of these questions.

    1. On 2023-10-27 19:33:35, user Federico wrote:

      The claim that you have generated brown adipocytes is overstated. There is no clear proof morphologically or by significant changes in gene expression (UCP1) that would support brown adipocyte character. I would revisit that experiment.

      Showing tissue that has formed (and analyze it histomorphological) would make the in vivo work much more convincing. In line with that, survival for up to 28 weeks seems overstated as IVIS data thresholding doesn't seem to be corrected for background noise.

    1. On 2023-10-27 15:59:31, user Ashraya Ravikumar wrote:

      In this manuscript the authors have tested the hypothesis that the MSA constructed by AlphaFold2 (AF2) contains information about the distribution of different conformational states of a protein. Whereas the current way of thinking about AF2’s MSA-predicted Cβ–Cβ distance maps focuses on their power to provide binary classifications of inter-residue contacts, the authors propose that Cβ–Cβ distances should instead be thought of as a set of collective variables that approximate a Boltzmann distribution. This is a novel hypothesis that lends AF2 the ability to decipher the conformational Boltzmann distributions of proteins. The authors test this in the contexts of protein dynamics, mutation impacts, and protein-protein interactions. They start with analyzing the correlation between AF2 contact distance and spin label distance distributions obtained from EPR spectroscopy using T4 lysozyme as a model, finding a general agreement despite broader AF2 distributions. Following this, they explore if AF2 can approximate free energy changes in systems that contain multiple biologically important minima, using EGFR KD studies for this purpose. AF2 accurately identifies altered contact distance distributions corresponding to active or inactive conformations in several mutations, indicating a sensitivity to alterations that stabilize particular conformational states. Next, they assess sensitivity to thermodynamically destabilizing mutations. AF2 was able to predict different contact distance probabilities for disruptive mutations like L198R in UBA1, but was less sensitive for milder mutations like L198A. Lastly, AF2’s sensitivity to protein-protein interactions was explored using the μ-opioid receptor (μOR). Although the helix displacement distances observed in the predicted structure of isolated and complexed μOR do not exactly match with expected values, AF2 did successfully predict differences in select contact distance distributions of active/inactive-state μOR. Demonstrating that Cβ–Cβ distance probabilities from the same AF2-learned distribution reflect distances observed in differentially behaving domains of a protein lends strong support to the hypothesis that AF2 contact distance distributions can approximate conformational distributions.

      The manuscript explores the correlations and sensitivities of AF2 predicted Cβ–Cβ distances across a variety of protein contexts, giving a broad view of its capabilities and limitations. Transitions between the various sections flowed well, and overall the writing was well worded and easily comprehensible. In addition, the presentation was balanced. It doesn’t just focus on the success of AF2, but also highlights where its sensitivities might vary or fall short, providing a balanced view of its capabilities. Given limited computational resources, the conformational space explored by MD and MCMC simulations is limited by their initial states. AI methods are instead limited by how informative their system definitions (MSAs and pre-set theoretical or experimental contact distance distributions) are, allowing AI methods, such as the AF2 method outlined by the authors, to more effectively sample conformational space. This is a very fascinating implication of their work which the authors have briefly mentioned in the discussion. This (and the connection to Figure 7 in the paper) warrants a deeper discussion, but the main conclusions the authors come to are within the scope of the manuscript, and are backed up by the evidence presented.

      There are a few points we would like to bring to the attention of the authors to strengthen the manuscript further.

      Major points:

      1.There are some difficulties interpreting Figure 2. <br /> (a) It is important to mark the distances between the two chosen pairs of atoms in the active and inactive state. Without this information, the purpose of Figure 2D is unclear and Figure 2D, F and G are difficult to understand. <br /> (b) What is the threshold distance to classify a state as active or inactive?<br /> (c) Figure 2E seems confusing with different axis and ranges.<br /> 2. In case of DDR1, does the MD simulations reflect the peak distances (between 7.5 and 10.0 Å for DFG-in and between 16.0 and 18.0 Å for DFG-out) observed for AF2 distance distributions? Also, the probability distribution shift towards shorter distances for Y755A does not seem particularly strong at first glance. Is this why the double alanine mutant was included? Are there also MD simulations of the double mutant that show a reduced preference for the DFG-out conformation?<br /> 3. The overall results on EGFR mutants are striking. Many of these mutants (most notably L858R have structures deposited in the PDB (ID:2ITT and many others) that are potentially part of the overall training of AF2/OpenFold. Can you comment on how this might affect the results?

      Minor Points:

      1. There is some ambiguity in the statement, “The central hypothesis of this manuscript is that the collective contact distance distributions predicted by AF2 contain relevant information that can approximate Boltzmann distributions provided the relevant conformational states can be adequately described by these contact distances.” We suggest adding to this such that a stronger connection is formed between the theory section and the remainder of the paper. For example, the authors could explain that the contact distances specified in each section are the set of CVs you describe earlier, “we identify a set of CVs, ξ = (ξ1, ξ2, …, ξm)...”. It would also be helpful to clarify that the distributions predicted by AF2 represent the ensemble averaged observable, as described by equation 4. Lastly, the authors mention that these distributions can approximate Boltzmann distributions, but this is somewhat vague. This could be reworded to say that AF2 distributions can approximate experimentally derived Boltzmann distributions of the same distance.
      2. The authors are comparing Cβ–Cβ distances determined by AF2 to spin label distances from EPR. This is explained in the methods section, but the procedure for adjusting the spin label distances to facilitate a meaningful comparison between them and the AF2 distances is somewhat unclear. To make a stronger justification for why these are comparable, the authors could clarify the procedure. For example, some context from the authors’ previous paper, De Novo High-Resolution Protein Structure Determination from Sparse Spin labeling EPR Data: “[distance from spin label] dSL is a starting point for the upper estimate of dCβ, and subtracting the effective distance of 6Å twice from dSL gives a starting point for the lower estimate of dCβ” could be beneficial. Including a rank correlation coefficient, as hinted above, could also help emphasize that the results demonstrate “similar relative probabilities among the contact distances for AF2 and EPR”
      3. In the comparison of distance distributions between AF2 predictions and EPR measures, the major peaks of the two distributions are similar but in certain cases (127CB - 154CB, 120CB - 131CB), some additional peaks are found beyond 10A. A statistical comparison of the distributions, perhaps using a KS test, will help in evaluating the significance of the similarities.
      4. Typo in Hamiltonian Equation 1 (should be momentum squared)
      5. In the T4 Lysozyme example, how were the six contacts between the 12 unique residues found?
      6. In Figure 5, the fourth row could have more discussion/explanation. What does the colorbar represent? There is no label.
      7. As mentioned earlier, the connection between the Discussion and Figure 7 is not well established. The authors could expand on their writing and/or make the figure more simplified to match the discussion better.

      8. Jessica Flowers, Angelica Lam, Ashraya Ravikumar, James Fraser

    1. On 2023-10-27 15:13:53, user JO wrote:

      Is it possible to show where the ecRNH and ttRNH would fall relative to the clusters in Fig. 9? Their identity to the AncA/B/C sequences? And key residues that vary between ecRNH and the most homologous Anc sequence?

    1. On 2023-10-27 14:47:25, user Joseph H Vogel Beckert wrote:

      "To add to this uncertainty, the pilot test coincided with international discussions on the fair and equitable sharing of benefits from the access and use of digital sequence information (i.e., genomic sequences) under the Nagoya Protocol adding increased uncertainty surrounding the legal compliance landscape57."

      There should be some mention of "unencumbered access" through the proposed modality of "bounded openness over natural information". The sentence above references a Comment from Nature Communications that trumpets "de-coupling" access from benefit-sharing. "De-coupling" means independence and is probably not what its 41 authors meant. Similarly, any reference to a multilateral mechanism for ABS without recognition of the overarching implications of the economics of information, i.e. the justification of "economic rents", introduces bias and thus undercuts the presumed scientific neutrality of the manuscript..

    1. On 2023-10-26 22:50:15, user ELSA COUVILLON wrote:

      Dear authors,<br /> Overall, I felt your paper was interesting to read and highly relevant to the SARS-CoV-2 pandemic. These findings could be extremely valuable for identifying preventive measures for mitigating disease transmission, and I thought the experimental question addressed by your paper and the experimental design –incorporating a PSV entry assay and a syncytia formation assay– was cohesive. However, when reading and presenting at a journal club, some questions and comments came up that I would like to share with you.<br /> First off, I would like to point out a few simple fixes that I found. For one, Figure 4 is titled “Effect of turmeric extract and curcumin on PSV entry in 293/ACE2 cells,” however, the experimental results exhibited in Figure 4 only deal with curcumin, so I feel renaming that figure would be more accurate. <br /> Additionally, I’m curious as to why in Figure 4b, the PSV entry assay treatment conditions included the following:<br /> non-treated 30 mins/SARS-CoV-2 16-18h<br /> curcumin 30 mins/SARS-CoV-2 16-18h<br /> curcumin 30 mins/SARS-CoV-2+curcumin 16-18h<br /> but did not account for the effect of non-treated 30 mins/SARS-CoV-2+curcumin 16-18h? I was curious as to the logic for excluding that particular treatment combination, which I feel could’ve been a good control for comparing the infection rate of SARS-CoV-2 compared to SARS-CoV-2/curcumin without the additional variable/impact of the initial 30 min treatment. As a side note, it might be beneficial to readers to make more clear, what is meant by “curcumin pre-treatment”; does that refer to the 30 min “black arrow” segment, or the 16-18h “gray arrow” segment in which the virus has a “+ curcumin” label? <br /> One final thing I want to point out is the use of statistics in this paper. You state that a t-test is used throughout, however, I believe that an ANOVA might be more effective here, not only to reduce the number of tests you have to run on the data (and therefore reduce the risk of making a Type I error), but also so that you can show the readers comparisons between each and every group, and not just between each individual group and the control. Additionally, it would be helpful if there were asterisks or “n.s.” consistently shown for every statistic (for example, this is done on Figure 5b, but not Figure 4d), along with a key on every graph indicating the significance levels indicated by each asterisk, to help clear up some confusion about interpreting significance and statistics. Going back to the Figure 4 example, in the paper, it is stated that, “The results indicated that curcumin reduced PSV entry, especially for curcumin pretreatment before the addition of PSV (P = 0.035)” in reference to Figure 4d; however, in the actual graph, there isn’t sufficient statistical representation to confirm this conclusion (no statistics are shown for comparing Cur 1uM and the control) and additionally, I had a hard time determining what defined the pre-treatment when flipping between Figures 4b and 4d.<br /> Ultimately, I feel the paper is a great start and could mainly benefit from a few changes to encourage more clarity surrounding the ways in which different treatments were defined, the labeling and annotation of figures, and display/application of statistical tests. I look forward to following it through pre-print.

    1. On 2023-10-25 00:53:17, user CDSL JHSPH wrote:

      Great work! I think this is very important for future research regarding T. cruzi and it's genome's contribution to Chagas disease. Sequencing this strain, whose whole genome has never been sequenced, is a significant contribution. Despite some limitations, this was done successfully and I think it will push others to work on sequencing genomes from other strains, particular those from field samples. I think this is a great step for further research in looking at the relation between transposable elements and multigene families. The methodology in this study was very convincing. I especially like the extra steps done to address the limitations of the Busco Score. I think comparing ORF length of assemblies from other strain with similar characteristics really helped improve your methodology. The paper had a logical flow, but I do believe limitations should have been further explained in the discussion. I think this would have really improved this paper. Overall, this was great work that opens up to more questions regarding this field which I hope this team or other researchers would look at in the future. Not only was a whole genome of this strain sequenced, but it was done using ONT nanopore sequence alone which can provide a less expensive method for sequencing T.cruzi genomes. A few questions that came to mind was how different do you think your results would have been if you used ONT nanopore sequencing with supplementation of other technologies. Also how different would your results have been if you used a field isolated samples instead of a lab strain? Do you think you would have found a greater correlation between transposable elements and multigene families?

    2. On 2023-10-25 00:37:30, user Jessica Garvin wrote:

      Hi! I found your research incredibly engaging to read about. The variety of test results that you shared was especially notable. Since publishing this paper, have you worked on any other projects similar to it? I think it would be an interesting find to see whether or not you would have similar findings with strains comparable to the Tulahuen strain. Wonderful job on your work!

    3. On 2023-10-24 01:24:43, user Anshule Takyar wrote:

      Hello! This is a good piece of work, and the value to the field is very evident. It is great to see novel sequencing methods like Oxford Nanopore sequencing being validated more and more, and by employing a Nanopore-only approach, you have probably helped to assuage some of the anxieties of others in the field regarding this technique. I had a few questions and recommendations regarding this technique. Have you sequenced T. cruzi, or the Tulahuen strain specifically, with short-read sequencing? Are there any hurdles involved with that? Also, do you think that by assembling this genome using the help of short-read sequencing, you would have gotten a better result? Additionally, I think that it would be helpful to show in a figure which coding regions are not impacted by transposable elements, as that would increase the significance of your work. Other than that, I really liked this work, and congratulations!

    1. On 2023-10-24 17:32:53, user Jianhua Xing wrote:

      It is nice to see more efforts on learning the governing equations of gene regulatory networks from single cell data, and thanks for mentioning our dynamo work. Congratulations on the work. I notice that some discussions on dynamo are not accurate --unfortunately it has happened repetitively in the literature such as stating dynamo requires data with metabolic labeling only and the vector field gives only lear relation between a regulator and its target gene. Related to what discussed here, with the dynamo vector field one can predict cell states NOT covered by the data. That is, dynamo is a generative model. So the criticism on using embedding is not justified. One uses low-dimensional manifold embedding (e.g. in Dynamo) to simplify the model (with reduced number of parameters to specify), and it is well-established that a dynamical system typically falls to a low-dimensional manifold after a transient period of time. A famous example is the 3-variable Lorenz model. Starting from any initial state, it falls to a strange attractor with dimensionality 2.06

    1. On 2023-10-24 15:20:08, user kamounlab wrote:

      We’ve discussed this note today and we have a question regarding Figure 1G. It's essential to ensure that RBA1 doesn't negatively affect the agroinfiltration process itself, which could potentially lead to reduced accumulation of the virus and reduced fluorescence, thereby impacting the interpretation of the results.

      To address this issue, the experimental design should include appropriate controls to rule out any interference of RBA1 with agroinfiltration.

    1. On 2023-10-24 12:41:18, user Ying Cao wrote:

      Apparently, EMT means change of cellular states/properties but not of gene/protein symbols. In the case of EMT, what are epithelial and especially mesenchymal states/properties are not known. What it the scientific meaning of the so-called epithelial-mesenchymal transition?

    1. On 2023-10-23 12:27:01, user Senthil-Kumar Muthappa wrote:

      This preprint article is now published, please see: Priya P, Patil M, Pandey P, Singh A, Babu V, Senthil-Kumar M. (2023). Stress Combinations and their Interactions in Plants Database: A one-stop resource on combined stress responses in plants. The Plant Journal, https://doi.org/10.1111/tpj...

    1. On 2023-10-23 08:13:46, user Richard Steeds wrote:

      This is a really interesting study in an ultra-rare syndrome that kills a substantial number of patients through cardiovascular complications.<br /> 1. As the authors have acknowledged, we have never seen evidence in any of our studies of sexual dimorphism in adult presentation with disease or on cardiovascular imaging, either by echocardiography or cardiac MRI. We have seen young men and women suffer cardiovascular complications at similar age of onset in their 20s and 30s.<br /> 2. Changes in left atrial area, isovolumic relaxation time and ejection fraction without similar changes in myocardial performance index or global longitudinal strain worry me, as in humans I would expect both to be early indicators of restrictive cardiomyopathy. All of these values are affected by both acute changes in blood pressure (and especially during anaesthesia) and by the longer-term effects of hypertension, so this is an important confounder but again acknowledged.<br /> 3. One feature that is expected in human studies of restrictive cardiomyopathy would be corroborative evidence of pulmonary hypertension, occurring as a result of elevated LV end-diastolic pressure, high LA pressure and thereby pulmonary venous hypertension. Was there any TR in the mice model and any measure of TR maximal velocity?<br /> 4. I am an adult cardiovascular imaging specialist who practices both echo and CMR. I am only too aware of the variability of echo measures of cardiac function on an intra- and inter-observer basis. At heart rates of 350-450 BPM, I remain very concerned by the reproducibility in small numbers of animals - although I recognise these numbers are considered adequate in the animal physiology world. When I look at the box plots, there is often a wide spread of results, and no idea is given in the manuscript of the intra-observer measurement for example of ejection fraction - I understand that the person was measuring blind and was a single experienced sonographer...but in our practice, we recognise that in experienced hands, EF may vary in humans at up to 10% between scans at heart rates of 70BPM.

    1. On 2023-10-19 01:02:59, user Jonathan Eisen wrote:

      Minor comment - in many parts of the manuscript you refer to "16S rRNA sequencing data". It would be more accurate to refer to this as "16S rRNA gene sequencing data".

    1. On 2023-10-18 18:45:43, user Vanessa Staggemeier wrote:

      Moura et al. evaluate the loss of suitability areas for non-flying mammals in the Caatinga in two future periods (2060-2100) under climate change effects and what would be the expected changes in the biotic composition of communities.

      The authors employed an interesting approach with restrictions on species dispersal in the models and the results contribute to predicting the effects of climate change in this biome.

      We see the importance of focusing on biotic changes and % of range loss, but it is our belief that adding the final predictions for each species in the supplementary material, in terms of maps and range shifts (direction of shift), it would be worth and informative because this information is important for managers and decision makers (those who manage conservation units but also to the researchers working on specific taxa).

      We also think that including a more detailed discussion about some species that have been modelled in other previous studies could enrich the work and make some of the results obtained here clearer. For example, why species with a wide distribution such as Callicebus barbarabrownae would lose their entire area of suitability in 2060? Other studies, such as Barreto et al. 2021 and Gouveia et al. 2016 found different results, could you attribute this to the methodological choices?

      We think the words used in the bibliographic review were not wide enough to include studies with mammals in the Caatinga because some important references are out of the included papers. The chosen words are mainly related to the biome or region. Maybe another approach would be to review occurrence records in a systematic way looking for articles with species names (as keyword) based on a preliminary list of mammals.

      Including latitude and longitude in the maps it would be more informative and including political division of states could help to subside discussion for specific regions of Caatinga.

      We wrote this comment during a meeting to discuss preprint papers that occurred by September, but I was able to post it just now.

      I saw that the paper was accepted yesterday, so I am not sure if our suggestions/questions will have some worth to the authors (feel free to reply or not), but we decided to contribute with them anyway.

      Many congratulations for your article! Although we think that some points could be different, we are sure that article is a nice contribution to understand potential effects of climate change in Caatinga :)

      Comment written at the Laboratório de Ecologia Vegetal, Evolução e Síntese (LEVES) at the Universidade Federal do Rio Grande do Norte, RN, Brasil. Joined this meeting: Vanessa Staggemeier, Hercília Freitas, Víctor de Paiva, Yan Gabriel, Alexander Chasin, Rhuama Martins, Vitoria Alves, Jose Nilson dos Santos, Rafael Rocha dos Santos, Maria Luiza and João Paulo Câmara.

      References<br /> 1) Barreto, H. F., Jerusalinsky, L., Eduardo, A. A., Alonso, A. C., Júnior, E. M. S., Beltrão-Mendes, R., ... & Gouveia, S. F. (2021). Viability meets suitability: distribution of the extinction risk of an imperiled titi monkey (Callicebus barbarabrownae) under multiple threats. International Journal of Primatology, 1-19.

      2) Gouveia, S. F., Souza‐Alves, J. P., Rattis, L., Dobrovolski, R., Jerusalinsky, L., Beltrão‐Mendes, R., & Ferrari, S. F. (2016). Climate and land use changes will degrade the configuration of the landscape for titi monkeys in eastern Brazil. Global Change Biology, 22(6), 2003-2012.

    1. On 2023-10-17 08:52:43, user DL wrote:

      Very interesting paper and deep insight into the mechanism. However, no functional data regarding the detergent or DTT conditions are shown. I'd really like to see electrophysiological recordings of HCN1_wt, HCN1_CC mutation and HCN1_CCA mutation under a) DTT application and b) CHS/LMNG application/incubation to show the physiological/functional relevance of the resolved putative Intermediate and Open states.

    1. On 2023-10-17 00:19:42, user Abram Magner wrote:

      We, the authors of ``A Deep Learning Architecture for Metabolic Pathway Prediction'', thank the authors for pointing out the existence of duplicate entries in our datasets and for pointing out that we did not upload all of our code for data download from the KEGG database.

      We have addressed the latter issue by uploading our data download script, keggpuller.py, to the project Github. This code was used to download molecule records from the KEGG database and store them in a commma-separated value format. This resulted in 6669 records. The dataset was then further processed to a simpler form to reduce each record to a SMILES string followed by a comma-separated list of letters indicating pathway class membership (this is smiles_property.txt). We refer to this as the multi-class dataset. We also considered the problem of classification of a compound as either being a member of a single, given pathway class or not. We refer to the resulting dataset as the single-class dataset.

      The authors are correct that the resulting datasets contain duplicate entries. The single-class dataset contains six duplicates out of 4545, while the multi-class dataset contains 1740 out of 6669.

      We have re-run our experiments on the datasets with duplicates removed. The results for single-class classification did not change. The table of results for multi-class classification can be found at this location.

      We note that the accuracies of most methods dropped, including ours. The accuracy statistics for ensemble logistic regression increased.

      However, we also note that the central results of our paper remain intact -- the relative ordering of accuracy of different machine learning methods (other than ensemble logistic regression) on the data remains the same, and the superiority of our method over the others that we evaluated remains. Indeed, this is expected because we ran all methods on the same datasets, using the same training/test split methodology.

      We have uploaded the de-duplicated datasets to the Github page. The authors are correct to encourage the use of the de-duplicated datasets. We will also post a correction to our paper.

    1. On 2023-10-15 07:36:09, user Ben Dickie wrote:

      Hi,

      Really nice work. Please consider reporting your DCE methods using the new OSIPI lexicon to improve standardization. https://onlinelibrary.wiley.... I’m very happy to help integrate the correct terminology (ben.dickie@manchester.ac.uk).

      Best wishes,

      Ben

    1. On 2023-10-14 20:57:10, user Christophe Leterrier wrote:

      Figure 3 is repeated 2 times in the pdf file, Figure 2 being absent. Is it possible to upload a corrected manuscript as revision? Thank you.

    1. On 2023-10-14 16:35:59, user Naveen Shankar wrote:

      Published version of this article is now available. <br /> Shankar N, Sunkara P, Nath U (2023) A double-negative feedback loop between miR319c and JAW-TCPs establishes growth pattern in incipient leaf primordia in Arabidopsis thaliana. PLoS Genet 19(9): e1010978. https://doi.org/10.1371/jou...

    1. On 2023-10-14 09:42:51, user Daisuke Kitamura wrote:

      We did not provided you the cell line, "40L-MEF", whatever it is. By the way, we generated "40LB" based on Balb/c 3T3 cell line, not on MEF, as described in the Ref. 26.

    1. On 2023-10-13 15:56:11, user Yichao Li wrote:

      Regarding "we observed that features correlating with open chromatin or active genes (such as ATAC-seq,HDAC1/2/3, or H3K4me1/2/3)", if you look at your reference 14, it says "HATs have been associated with active and HDACs with inactive genes."

      I'm wondering why HDAC is "active marker" in this paper?

      Thanks,<br /> Yichao

    1. On 2023-10-10 13:37:06, user Tom Langton wrote:

      There is a distinct lack of transparency becasue data are not linked in supplementary material and neither is the stata code. Even if the code was there it would be difficult to reproduce – stata is not very widely used.

      Does the analysis decisively link badger culling to decline in bovine TB in cattle? Culling is confounded with complex changes to gamma and other testing and other measures. There are places in the ms where a claim is made for a link ‘The effect of badger culling…’ but then later: ‘However, this data analysis cannot explicitly distinguish…….’ APHA have stated more than once that the breakdown data alone are insufficient to show an effect of culling.

      However, the DID approach is inappropriate because the 52 cull and pre-cull study areas are surrounded by and in close contact with each other and so are not adequately discrete in space and time, breaking a DID requirement. Notably in the four-year period 2016/17 -2019/20 pre-cull and cull areas closely juxta position. Pre-cull and cull interventions may influence change in adjacent pre-cull and cull areas in an irregular and unpredictable manner, via the constant movement of cattle with different intervention histories.

      Some of the very important bTB testing controls used and the timing of their introduction are not correctly described and some not even mentioned.

      The approach mixes data from 46 High Risk Area study areas with 6 from the Edge Area. These have very different epidemiological and disease control history profiles and the reason for mixing them is not explained. Pre-cull gamma testing was intense in the Edge Area. While the manuscript mentions additional gamma testing from 2017, gamma testing was erratic between areas and over time. There were considerable numbers of gamma reactors in many of the cull areas in cull years 1 and 2 with similar disclosures to years 3 and 4 but pre-cull use in the HRA was generally low.<br /> In both HRA and Edge areas OTFW incidence was declining when many of the additional disease control rules were intensified, and badger culling introduced. The government chief scientist view was that distinguishing and determining with any precision any contribution of badger culling to disease control is not possible, is therefore maintained. It is impossible to distinguish between the effects of badger culling and disease control measures using the DID approach in any meaningful way.

      The comment made on being unable to match cull and control is unevidenced and a 2022 published and peer reviewed study of this has not been cited, nor alternative approaches such as matching a series of individual farms in cull and control which would have been simpler and easier to monitor on a quarterly basis since 2018, as was the expectation of a High Court ruling.

      The suggestion that incidence is the better indicator of true burden goes against APHA’s own epidemiology and the greatly clarified understanding of SICCT test sensitivity and specificity. The specificity change resulting from SICCT severe interpretation can be estimated and applied to OTFS, providing, with OTFW, a safe index of known infection. Gamma testing has shown numbers of unidentified reactors in both identified bTB infected and unidentified herds, and this ‘hidden’ reservoir remains undocumented although its size can be deduced.

      OTFW relates by its nature to older infections with lesions, yet it is newer infections (OTFS) that indicate disease control success (elimination) more accurately, over time. There is no reason to believe that OTFS+OTFW (as above) is not the superior approach and that OTFW is half of the full picture. During the RBCT, prevalence was growing considerably and OTFS rising so the analogy made in this manuscript is inappropriate and trying unconvincingly to defend the historic reference source.

      By reducing the pre-cull analysis to one data point the significant pre-cull decline is hidden and this also masks true trends.<br /> Because the methods are inappropriate, the results are flawed and the conclusions are flawed. There is no way to distinguish between different interventions and change in herd breakdowns since 2013 with the approach taken.

      There is also need to see clarification of the analysis that is presented in the Appendix – this does not seem to be the output from the constrained DID analysis, but something else not fully described in methods which ‘matches’ it – which stata process was used ? It is the first analysis referred to in the main text. As well as showing that the BCP effect accounts for less than 2% of breakdowns it doesn’t look quite right that the BCP effect is based on error dof – pseudoreplication?

    1. On 2023-10-12 15:56:16, user Michael McLaren wrote:

      It would be useful to see a comparison to another method that also uses a Poisson / Multinomial distribution to handle issues associated with low + zero counts. In particular I would be very interested to see a comparison to Justin Silverman's fido package (https://jsilve24.github.io/..., though since fido is a Bayesian framework I imagine the comparison may not be as straightforward.

    1. On 2023-10-11 14:01:06, user Gilles wrote:

      Is there any positive control for FoxP3/CD25 stainings ? the cytometry stainings are so poor it is difficult to conclude anything.

    1. On 2023-10-11 10:42:55, user Vladimir Chubanov wrote:

      The paper presents an interesting model. It would be great if the author would attempt to connect the model to available experimental evidence. For instance, clinical assessment of the patients with loss-of-function mutations in TRPM6 and conditional mutagenesis of Trpm6 in the kidney vs intestine of mice demonstrated the prime role of intestinal magnesium absorption in the systemic balance of magnesium.

    1. On 2023-10-09 12:16:03, user Taise Gonçalves wrote:

      First, I would like to congratulate the authors, because this article is very well done. The diagram presented at the end of the introduction (Figure 1), exemplifying the expected results, adds a lot to understanding the text and it is an enriching differentiator for the manuscript. The data analyzed were obtained from environmental monitoring for 3 decades, which the authors were able to synthesize in very concise and accurate results. It certainly represents the best assessment to the hypotheses of pre-adaptation and limiting similarity to date.

      Taíse Gonçalves - Master's student - Fungi, Algae & Plant Biology Program - UFSC - Brazil (On behalf of the PLENTBio Journal Club; plentbio.wixsite.com/alcant...:gXjqaj9KUVrPkIjzaJ8r_UkXvwc "plentbio.wixsite.com/alcantaralab)")

    1. On 2023-10-09 12:13:10, user Taise Gonçalves wrote:

      The main conclusion of this research states that oceanic islands showed higher phylogenetic endemism, based on both metrics used by the authors, i.e. denoting palaeoendemics and neoendemics. This pattern, however, have been already stated in a recent study (Veron et al. 2019). In this sense, the discussion about the processes involved in the origin of such floras could be improved by the ideas presented by Vasconcelos et al. (2021). In this study, the authors propose that the terms neoendemism and paleoendemism should be replaced by assessment in relation to the actual biogeographic and macroevolutionary processes that had occurred.

      Moreover, although the authors provide a methodological discussion regarding the scale of the areas analyzed, a stronger emphasis should be put on it. Several large continental areas, for instance, represent large vegetation domains (i.e., Mata Atlântica and Cerrado), which include high number of endemism however unevenly scattered in island-like habitats throughout these areas.

      1. Vasconcelos, Thais; O’Meara, Brian C.; Beaulieu, Jeremy M. Retiring “cradles” and “museums” of biodiversity. The American Naturalist, v. 199, n. 2, p. 194-205, 2022. DOI: https://doi.org/10.1086/717412

      2. Veron, S., Haevermans, T., Govaerts, R. et al. Distribution and relative age of endemism across islands worldwide. Sci Rep 9, 11693 (2019). https://doi.org/10.1038/s41...

      Taíse Gonçalves - Master's student - Fungi, Algae & Plant Biology Program - UFSC - Brazil (On behalf of the PLENTBio Journal Club; plentbio.wixsite.com/alcant...:gXjqaj9KUVrPkIjzaJ8r_UkXvwc "plentbio.wixsite.com/alcantaralab)")

    1. On 2023-10-09 12:05:37, user Taise Gonçalves wrote:

      I congratulate the authors for the study and would like to add a perspective that could improve the reach of the manuscript, as well as to clarify a specific point.

      1. The three hypotheses proposed (lines 171 - 185) has been described as the predicted associations, reflecting correlation patterns instead of the causal mechanisms leading to those patterns. As an example of correlation, in discussion (line 437), the authors report that the higher taxonomic, functional, and spectral diversity found at middle elevations has already been tested all over the world. Could the focus of the hypotheses be stated as the process(es) behind these patterns instead of the correlations per se?

      2. The species Phacelia secunda was selected to analyze intraspecific trends between traits and environment, based on the fact that it is present across the elevation gradient (line 224). It would be interesting to know if Phacelia secunda is the only species occurring along the all elevation gradient. If not, why the authors selected it specifically?

      Taíse Gonçalves - Master's student - Fungi, Algae & Plant Biology Program - UFSC - Brazil (On behalf of the PLENTBio Journal Club; plentbio.wixsite.com/alcant...:gXjqaj9KUVrPkIjzaJ8r_UkXvwc "plentbio.wixsite.com/alcantaralab)")

    1. On 2023-10-09 11:26:07, user Arda Sevkar wrote:

      It appears that an incorrect strain was used for the alignment of Mycobacterium leprae. As indicated in the supplementary materials, the MRHRU-235-G strain was utilized for this purpose. Notably, the NCBI genome page designates this strain as the "reference strain". Unfortunately, that's not true. In the literature, alignment and genotyping are consistently carried out using the strain labeled as "TN" (NCBI Genbank accession number: AL450380.1)."<br /> Additional information regarding this subject is available in the following sources: Pfrengle2021, Krause-Kyora2018, Schuenemann2018/2013, Benjak2018, Monot2009

    1. On 2023-10-09 08:48:33, user ALFONSO DARMAWAN wrote:

      Hello,

      First of all, I enjoyed reading through the whole paper and it was really interesting to see the single suspension cell specifically in the progress of FRT. I would say the paper has showed very thorough and clear figures overall; nonetheless, I would love to follow-up with some suggestions regarding some of the figures. In figure one, I have seen the visual profiles between the Diesterus and Estrus cycles; however, it would be great to see the whole visuals for all 4 cycles to have more thorough comparisons how the cells are phenotypically changed over each cycle. In figure 2, I have seen cell-expressions for BEpC, MAIT, and F were not showed in the b figure because I saw some significant changes in between phase for those expressions and it would be nice to see them within the plot as well. In addition to figure 3, might as well of showing the scRNA-seq data in other cell-type expressions of Tgfb2 and correlate them with their most corresponding expressions within each of the organ. Lastly in figure 4, it would be great to also show us the other expressions besides Alpl because it's been slightly confusing to change every expression from one figure to another without vivid and brief explanations alongside with it. Thank you!

    1. On 2023-10-06 12:37:11, user Ashok Palaniappan wrote:

      An expanded, revised and advanced version post peer-review is now available [open-access]:<br /> Sarathi, A., Palaniappan, A. Novel significant stage-specific differentially expressed genes in hepatocellular carcinoma. BMC Cancer 19, 663 (2019). https://doi.org/10.1186/s12...

    1. On 2023-10-05 12:53:24, user Matteo Brilli wrote:

      I was checking the multialignment provided for download on the website. I am not an expert of supermatrix approach, but I have 20 years experience with phylogenetics, even if it is not my main occupation. Now, it turns out the multialignment has NO positions where all sequences have a non-missing character. The median number of Ns per sequence is around 32k and the alignment has 36327 sites. Across those sites, the minimum number of Ns is over 700, with a median number of Ns per site around 4000. Now, my question is, is ML able to reconstruct a satisfactory phylogenetic tree in these conditions? I understand missing data can be accounted for during reconstruction, but I suspect that if there are only (or almost only) missing data, the approximation will be far from reality.

    1. On 2023-10-05 10:36:59, user Oliver Wright wrote:

      Very interesting work! We have attempted a similar approach to understand the evolution of conserved viral protein domains, and found that the alignments generated by Foldseek for our particular dataset were of insufficient quality to generate a reliable phylogenetic tree. We also tried to generate alignments using 3Di sequences, but again struggled to generate reliable alignments due to divergence. We're curious whether you have found a way around this with your approach. Does your analysis workflow include a quality control for the alignments, or are you using the unaltered Foldseek output? Would you be willing to share your alignments?

    1. On 2023-10-05 06:23:48, user John McBride wrote:

      Thanks for the comment. This is a very good question. I will refer to the energy-minimized structures as "relaxed" and otherwise "unrelaxed". In this work I only analyzed the relaxed structures.

      There were so many different things to check that I never got round to checking the effect of energy minimization originally, but I did make sure to save all of the unrelaxed structures. So I re-ran some of the analyses (originally done on the relaxed structures) with the unrelaxed structures.

      (1: Structure correlations) When comparing AF-PDB correlations for pairs of structures where sequences differ by 1-3 mutations, relaxed and unrelaxed structures give almost identical results. For the case of no mutations, the correlations are actually higher for unrelaxed structures (r=0.38) compared to relaxed structures (r=0.33). This would reduce the residual correlations in Figure 1H by about 0.05. For reference, in Figure 1H the residual AF-PDB correlations range from about 0.15 to 0.35.

      (2: Blue fluorescence correlation) I checked the strongest AF-phenotype correlation, from Figure 2C. For unrelaxed I get r = -0.92, for relaxed I get r = -0.93.

      It seems that the energy minimization does help, but it is certainly a minor part of the overall prediction.

      Bear in mind that this analysis is nowhere near as extensive as what went into the paper, so I might have missed something. The paper has now been accepted, so I don't think it is possible to add this in a new version.

      Thanks again for asking this important question. I'm personally glad to know the answer (even if it is a bit preliminary).

    2. On 2023-09-21 08:42:03, user Diego del Alamo wrote:

      This is a comment about version 5 of the manuscript.

      These results are thorough, compelling and persuasive. They also stand in contrast with other papers, published in the aftermath of alphafold's release, that argue the opposite.

      The main concern for me is the absence of any testing or discussion surrounding the relax step of the pipeline - the manuscript never uses the words "relax", "minimization", and "openmm" (the package used by alphafold for all-atom minimization), and I did not find details in the accompanying github repo. It is therefore unclear how much of the results should be attributed to the neural network itself and how much should be attributed to the minimization step following structure prediction. We can't rule out the possibility that the strain being measured results from this second step. Were that the case, it would cast doubt on the role of the alignment and templates as the authors suggest in the discussion.

    1. On 2023-10-04 01:20:14, user Laboratório de Interação Veget wrote:

      Dear Authors, I am Elaine Cotrim Costa, a researcher at the Federal University of Minas Gerais (Brazil), affiliated with the Plant Interaction Laboratory (LIVe) coordinated by Professor Juliane Ishida. LIVe hosts an activity called the "Preprint Club," where we select preprints for reading and critical review. I have chosen your preprint: "The Penetration of Sunflower Root Tissues by the Parasitic Plant Orobanche cumana Wallr. is Intracellular." This is an interesting, well-written, and well-illustrated paper describing a robust and scientifically sound study. The study demonstrates that intrusive cells invade living host cells intracellularly, leading to the degradation of the cell wall. These results can contribute to the selection of candidate genes for resistance to the parasitic plant Orobanche cumana. In our discussion of the paper, we have some suggestions for you to consider. In general, the mechanism of intracellular and extracellular penetration of haustorium has been discussed in parasitic plants. Therefore, we suggest that the main contribution of the article to the state of the art of parasitic plants should be made clear in the introduction, discussion, and conclusion.

      Title <br /> Line 2: I suggest including the name of the sunflower species and the plant families in the title, and removing the full stop. <br /> Line 5: What is the authors' affiliation? I suggest including this information.

      Key message <br /> Line 12: Please check the species name Helianthus annus L. It looks like a letter "u" (Helianthus annuus L.) is missing. <br /> Line 17: I suggest removing Orobanche cumana from the keywords, as it is already in the title, and adding another keyword to broaden the scope of article search.

      Introduction <br /> Line 42: I suggest including the author of Orobanche cumana. <br /> Line 43: Remove the comma. <br /> Line 44: Which component of the root exudates are you referring to? Could you specify? <br /> Line 54: Could you please provide the full name of the gene? <br /> Line 57: I believe it's important to specify how the phloem connection is established, as it has received less coverage in the literature compared to xylem connection. <br /> Line 72: I suggest leaving only 'Orobanchaceae' in the parentheses. <br /> Line 74: For standardization, include the family name 'Pelargonium zonale' and remove 'family' from the parentheses for 'Convolvulaceae.' The ending 'aceae' already indicates the family."

      Materials and methods <br /> What is the sample number? I suggest including light microscopy and Toluidine Blue O staining analyzes in the text.

      Results and discussion <br /> Line 170: Insert a comma after “By contrast” <br /> Lines 181-183: I was intrigued by how the nutrient transfer process occurs in the early stages. Do you have any hypotheses? Figures: It would be interesting to insert an acronym in the figures indicating parasite plant (P) and host plant (H), as well as the host and parasitic plant tissues.

      Figures: I suggest positioning the figures vertically, as the sections are longitudinal.

      Concluding remarks <br /> Could you provide answers to questions 2 and 3 and consider including at least one sentence addressing these questions posed in the introduction?

      References <br /> Lines 243, 286, 292, 294: Please check the reference pages. <br /> Line 254: Please verify whether the journal name should be abbreviated. <br /> Lines 255 and 258: Please check if the author's last name is Dos Santos or just Santos.

      Sincerely yours, <br /> Elaine Cotrim Costa

    1. On 2023-10-03 12:21:32, user Ashok Palaniappan wrote:

      A much enhanced version has been peer-reviewed and published in PeerJ doi: 10.7717/peerj.14146<br /> The implementation of miR2Trait is supported with a GitHub wiki.

    1. On 2023-10-03 08:21:55, user Daniel Hodson wrote:

      Very nice paper. Lots of future potential for these DDX3 reporters. Experiments done in a male line. Is DDX3Y expressed in these X-degraded cells?

    1. On 2023-10-03 07:47:00, user Matthias Hoetzinger wrote:

      Nice work!

      A question regarding interpretation of ????:

      In the discussion it says:<br /> "For the extreme case C. burnetii, the idea of ???? = 0.29 means that the most similar genome in a different community within a network of over 200 thousand genomes shares only 29% genetic identity with the representative genome..."

      Here it should probably say:<br /> "...shares only 71% genetic identity with (or shows 29% genetic dissimilarity to) the reference genome...", right?

    1. On 2023-10-02 17:42:18, user Neil Greenspan wrote:

      The manuscript by Killian et al. is a valuable contribution to the investigation of both the biological and biophysical aspects of the humoral immune response elicited in the context of allogeneic organ transplantation. I do, however, have some reservations regarding the interpretations of the authors.

      1)<br /> The authors suggest that individual amino acid residues shared between an<br /> allogeneic HLA antigen and a self-HLA antigen should be viewed as “self.” I<br /> view this act of classification as problematic. When a donor HLA antigen<br /> differs by one or more amino acids from a host HLA antigen encoded at the same locus, the entire protein is classified, at least from some perspectives<br /> routinely adopted in transplantation immunology, as non-self.

      One way to rationalize this view, which may conflict with the perspective expressed by the authors in this manuscript, is to suggest that what matters in<br /> antibody-antigen interaction are the thermodynamic roles of the amino acids that constitute HLA antigens, not their identities. The claim is that the relevant biochemical/biophysical properties of a given shared amino acid at a particular position in the primary structures of the self and allogeneic HLA molecules can be altered meaningfully as a consequence of the one to several amino acid differences between these proteins. For example, a lysine or tryptophan that is oriented slightly differently in the self vs. the allogeneic molecules or that is more or less likely to fluctuate in certain directions is not necessarily thermodynamically equivalent in the two proteins.

      2)<br /> If the above assertion is accepted, then the claim that breaches of tolerance<br /> are critical for damage to the allograft is not demonstrated. While it is of<br /> interest to know that self-reactive B cells are generated it is not clear from<br /> this study that the antibodies produced by these B cells cause graft damage in vivo. While I acknowledge the evidence that autoreactive anti-A*24:02 antibodies can bind to allogeneic A*01:01 with potentially meaningful intrinsic affinities, that is a necessary but not sufficient condition for contributing meaningfully to clinical allograft tissue damage, especially in the context of a single patient with an autoimmune disease. Experiments designed to test the hypothesis, in a broader range of transplant patients, that such antibodies do contribute to allograft rejection episodes would be of interest.

      In the context of the potential role of autoantibody responses in allotransplantation, it has been accepted for some years that generation of autoantibodies to a variety of proteins can accompany alloimmune responses to an allograft. Some investigators have offered evidence that the presence of such antibodies is associated with damage to allografts. At present, I do not think we know with certainty the extent to which, if at all, such autoantibodies contribute to allograft damage or whether they can do so in the absence of pathogenic alloantibodies.

    1. On 2023-10-02 00:06:33, user LEVIn - Unicamp wrote:

      We discussed this preprint in our journal club and enjoyed reading it. We collectively agreed it's an exciting contribution to understanding how biological invasions shape invasive species' trophic niche and functional morphology in new environmental contexts. We all think the manuscript is well written and the figures are excellent! During our discussion, a major point that came up deals with how the hypothesis (lines 88-90) is motivated and then connected with the results. A more conceptual contextualization of the hypothesis in the introduction (e.g., explaining the ecological release hypothesis in the 3rd paragraph) could help readers to generalize the results beyond the study system and attract a more diverse readership interested in niche variation and biological invasions. Also, as the results combine a substantial body of statistical analyses aiming to understand variation in functional morphology and trophic niches across species, ontogenetic stages, sexes, and invaded vs. native ranges, presenting predictions after the hypotheses could help readers to navigate the results. For example, in light of the ecological release hypothesis, what is expected regarding morphological and body size variation across native and invaded areas? Our final point of discussion is related to the interpretation of the observed niche contraction in the invaded range. As replicates representing invaded vs. native ranges are sampling sites in space (Fig. 1), clarifying whether observed niche contraction emerges via lower variability in resource use across sites and/or within sites would be interesting. This is a key point to connect the results with the ecological release hypothesis. I hope you find these comments constructive; discussing this manuscript in our journal club was great. Congrats on your work, and good luck with the following steps!

      Laboratório de Ecologia das Variações Individuais (LEVIn), State University of Campinas (Unicamp), Brazil

    1. On 2023-10-02 00:05:18, user LEVIn - Unicamp wrote:

      We discussed this preprint in our journal club and enjoyed reading it. We collectively agreed it's an exciting contribution towards a more efficient and comprehensive use of camera traps as a powerful tool to monitor biodiversity. We appreciated the concerns the authors had to create a user-friendly and flexible approach, which will certainly appeal to a diverse public of ecologists and wildlife biologists. As tropical ecologists, most of the questions that came up during our discussion were related to applying this approach to tropical, species-rich ecosystems. For instance, we wondered whether models would perform similarly (e.g., classification accuracy) in megadiverse communities where the local pool of species is larger and morphological variation (both across and within species) may also be amplified. Would this imply having a more robust training set? We understand this is not something trivial to predict based on the current set of species, but a deeper exploration of how species' traits influence prediction accuracies would be very welcome in this direction. For example, does the model have lower performance for species with smaller body sizes and/or coloration more similar to the background? Or perhaps within groups of species that are more similar in size? We also wondered whether detection and classification accuracy varies across diurnal and nocturnal records, which could bias predictions. Congrats on developing such a powerful tool for ecologists and wildlife biologists, and good luck with the next steps of this work!

      Laboratório de Ecologia das Variações Individuais (LEVIn), State University of Campinas (Unicamp), Brazil

    1. On 2023-09-30 15:41:02, user Prof. T. K. Wood wrote:

      No credible link to persistence here as all toxins, when overproduced, increase persistence (should cite refs showing this). False: persisters poorly understood (should cite only mechanism of 100S ribosome dimerization). No credible evidence of NADase and cell suicide. Should cite 1st report of TAs and phage defense and no evidence of TAs and abortive infection. So usual lack of appropriate citation by Jenal Lab.

    1. On 2023-09-30 14:04:49, user Erik Choueri wrote:

      The study seeks to address the significant question of whether rivers act as barriers to gene flow in Neotropical primates—a topic that carries substantial weight in understanding primate evolution and speciation processes in these diverse and ecologically important regions. While the overarching theme is commendable, there are certain aspects that warrant attention and further refinement: <br /> Although the purpose of the study is to test the hypothesis of rivers acting as barriers to gene flow in Neotropical primates, the introduction excessively focuses on the Amazonia. We suggest to bring the impact of rivers on primates in other Neotropical or global biomes. Additionally, the role of other physiographic barriers in primate structuring has been underexplored. Many statements lack references, some of which are fundamental to the work, such as a source showing primate distributions associated with rivers (lines 84:87) or proposing river width as a proxy for molecular dissimilarity in undersampled areas (lines 116:117). The justification for using mitochondrial DNA markers is weak and exposes limitations that are not exclusive to mtDNA. The line 140 brings confusion about the geographical scope of the study, stating that it would cover only South America and not the Neotropics. The objective 3 proposes to model geographical regions that lack additional taxonomic explorations, but no methodology is proposed for this, and the results and discussion briefly touch on such topic.<br /> Overall, there is a lack of clarity in the methodology description, and we suggest that the authors assume that the analytical details of a scientific paper should prioritize its replicability. Regarding spatial analyses, how accurate are the IUCN Red List distributions for all Platyrrhini species or to what extent were physiographic barriers used as estimates to define the boundaries of these polygons? Also, IUCN specialist maps would probably use rivers as the limit of the distribution for species species and subspecies, thus, testing rivers as barriers using this dataset could potentially be a bit circular. What criteria were used to define "mountains" (a threshold for altitude? Topographic roughness? Any reference?). In the case of Andean Mountains for example, instead of separating sister species-pairs, the separation could be older and at the genus level. It is also inappropriate to consider the width of the river at the midpoint of the species boundary, as organisms could potentially cross it at any point, especially where the river is narrower. It is also unclear how (or if) the effects of geographical distance on genetic divergence (isolation by distance) were controlled.<br /> Regarding molecular analyses, does the quantity and spatial extent of sampling adequately represent the distribution and haplotypes of species? Could taxonomic uncertainties be affecting these data? Is the locality of these sequences described as geographic coordinates or the name of the sampling site? How were the data linked to species: were DNA sequences obtained from taxonomic studies confirming identification or the authors verified the respective collected specimen? Were phylogenetic topologies and genetic distances inferred considering which nucleotide substitution models? Was any analysis of model selection per partition performed (e.g., PartitionFinder)? If not, some justification is needed for the methodology chosen.<br /> Maps of sampling points and phylogenetic trees would greatly facilitate the overall interpretation of results, mainly Figure 3. Furthermore, it is important to explicitly assume the expected topology for a scenario in which the river promoted speciation. Would it be reciprocal monophyly? Additionally, we suggest that the results of genetic dissimilarity and statistical analyses be placed in a table (lines 289 to 308). The lack of phylogenetic support listed in "Suspect taxonomy" should be interpreted with caution, as it may present analytical biases related to the use of few mitochondrial sequences considering inappropriate nucleotide substitution models.<br /> We miss the integration between the results and the literature. Much of the early discussion refers to a redundant description of results (lines 374:404), followed by information about the dispersion of Platyrrhini across rivers. We suggest that these two sections could be worked cohesively and in a complementary manner. The link between the low phylogenetic support in areas without geographical barriers and the suggestion of incorporating geographical barriers into taxonomic descriptions is not clear. The low supports "when no geographical barriers was evident" may reflect deficient haplotype sampling in these areas, since molecular sampling is generally denser near rivers than interfluves in Amazonia. Finally, a point brought up in the Abstract but missing from the discussion is that the findings of the study suggest that the formation of riverine barriers coincides with speciation events, but nowhere are the dates of river formation or species diversification mentioned. Such an interpretation should be avoided since the genetic structuring can be promoted by rivers in vicariant or secondary contact contexts.

    1. On 2023-09-30 14:02:05, user Murali Gopalakrishnan Meena wrote:

      Our preprint has been accepted for publication in PNAS Nexus (https://doi.org/10.1093/pna..., which is openly accessible. The published article will be linked to this preprint soon. We have significantly revised the contents of the preprint based on feedback from the peer-review process. Please use and refer to the published journal article for the latest information.

    1. On 2023-09-30 10:46:37, user Dilawer Khan wrote:

      The authors fell into the same trap as most other authors in using admixture proportions to infer relatedness of contemporary populations to various ancients in figure 5.

      For example, a sanity check using IBS or even something like qpWave in cladality mode would have shown that WHG is NOT more related to Southeast Asians and Indians than to Near-Eastern populations. The same applies to other maps in figure 5.

      Most scientists tend to forget the basic principles of ancestry proportions, to wit, ancestry proportions will change based on how distal or proximal the sources are to the target individuals. The accuracy of the calculations depends on how closely the actual sources align with the test sources.

      For example, in their admixture calx the authors use sources such as ANF and CHG which are more proximal to Near-Easterners than to SE Asians and Indians to infer WHG proportions. Although arguably ANF and CHG are important sources for Near-Easterners, they’re not for SE Asians. That’s why figure 5 incorrectly shows WHG higher in SE Asians than in Near-Easterners.

      Had the authors used more proximal sources such as South Asian or SE Asian Hunter gatherers, then the result would have been lower WHG in SE Asians than Near-Easterners which would have been correct.

      In conclusion, authors should not use a admixture proportions to infer relatedness between two populations. One-to-one comparison methods such as IBS, IBD, or qpWave with a proper set of outgroups will yield much more accurate results.

    1. On 2023-09-29 22:35:52, user Brooke Morriswood wrote:

      Note that this preprint (v2) was updated as a result of peer review of the first version (v1). It is however non-identical to the final published version in Journal of Cell Science. For that, FigS2 was deleted, and Figure2 was moved into the supplementals; in addition, around 1000 words were cut (mostly from the Discussion) in order to comply with JCS' figure/word limits.

      As such, this v2 version of the paper is a kind of "director's cut" ;-p<br /> For the succinct version, visit the JCS version; for aficionados of this particular topic, you can enjoy the longer version here. :-)

    1. On 2023-09-29 21:10:20, user disqus_mtg7x7eXMb wrote:

      The pre-print Kim et al. [1] shows promising pharmacodynamic data for an LRA (Galunisertib, given as 20 mg/kg for 14 days, in multiple cycles) to purge the SIV reservoir in HAART treated SIV infected monkeys. They corroborate the finding with the use of a radiolabeled anti-env imaging probe, which the authors claim can be used to detect tissue areas of increased viral replication in the body when the probe uptake in those areas increases.

      This radiolabeled probe was already used in a 2022 publication [2] from the same team (Samer et al. JCI-Insight, reference number 35 of the Kim et al. pre-print [1]), to show the increase in SIV viral production in monkeys treated with HAART following the LRA administration given for a shorter period of time at lower doses (5-10 mg/kg for 7 days).

      In the 2023 pre-print, however, the first cycle of the LRA did not induce those very high increases in probe uptake in lymph nodes or the gut of animals as reported in the 2022 [2] paper in which the animals received the LRA at lower doses for a shorter period compared to the 2023 pre-print [1].

      Why higher doses and longer duration of the LRA in 2023 are not revealing those high increases in probe uptake seen in the 2022 paper?

      One possible explanation is that those high increases in SUV uptakes seen in the 2022 paper are the result of non-specific uptake of the probe, based on certain details of the 2022 published images (more in note-*1).

      The latter seems a reasonable explanation for the Samer et al. paper [2] given that the LRA showed a systemic effect (see Suppl Fig S6 in Samer et al., in which the effect of the LRA is measured in the peripheral blood mononuclear cells), hence it is unlikely that the red spots in the PET images show up only in the Axillary cluster of lymph nodes ipsilateral to the injection sites and not in any other lymph nodes clusters in the body. See for instance video 3 and video 4 of the [2] paper in the links repasted below for quick access (under note-1*), the two animals with the highest increase in Lymph nodes uptakes show red spots only in the Axillary nodes ipsilateral to the injection sites, but not on the opposite site of the Axillary nodes nor in other lymph nodes clusters of the body, such as the inguinal lymph nodes.

      The authors however showed that the LRA did induce an increase in viral replication from PCR of inguinal nodes tissues shown in Table 2 and Fig 4A of [2]. For instance, the A14X064 showed ~100 fold increase in CAVL-RNA in inguinal nodes, yet from video 4 https://insight.jci.org/art... the only nodes that light up in red in the PET images are the Left Axillary nodes ipsilateral to the extravasation of the injection site on the Left arm of the monkey. <br /> Lack of increase in specific binding of the probe in the lymph nodes, despite the evidence of increase in viral RNA in some of those tissues based on PCR, points to a lack of reproducibility of the anti-env imaging system, or, at most, to a poor sensitivity of the imaging system.

      On the other hand, this lack of reproducibility that comes across by comparing the 2022 and 2023 imaging data, which are based on previous two publications from the same imaging team in 2015 [3] and 2018 [4], questions indeed those earlier two nonhuman primates papers [3, 4] too, in which the authors showed evidence that this imaging system is capable of detecting residual levels of viral replication in HAART treated animals, the latter being an attribute of an imaging systems very sensitive to detect changes in target (gp120) molarity. <br /> The latter consideration assumes that the binding affinities of the radiolabeled F(ab’)2 fragment of the 7d3 used in [1, 2] and the radiolabeled 7d3 used in [3, 4] are similar, which seems a fair assumption based on what is implied in the Methods sections of the [1, 2] articles, although in vitro binding data have not been reported in the [1, 2] articles (more in note-*2).

      Similarly, there is no evidence of increase in gut SUV levels after the first two weeks of Galunisterib administration in the 2023 pre-print Kim et al. [1]. This contrasts with the observation reported in the 2022 [2] of a substantial increase in gut uptake seen for instance in animals (A14X027 (video 1) or A14X013 (video 7) or A14X064 (video 4)) after only one week of the LRA administered at lower doses for shorter periods compared to the [1] 2023 study in pre-print.

      An alternative explanation for the increase in gut radiotracer uptake seen in the 2022 paper is that the increase in bowel uptake reflects a well-known phenomenon of non-specific intraluminal uptake of the radiolabeled antibody\F(ab’)2 fragments [5, 6] (see more under note-*3.1)).

      In other words, the hypothesis that the increases in probe uptake in lymph nodes and the gut seen in the 2022 paper after the first LRA-cycle are fully explained by non-specific uptake of the probe appears consistent with the lack of increase in probe uptake in the same anatomic compartments in the 2023 study in which animals received the same LRA at higher doses for longer periods of time.

      Finally, another important difference between the 2022 [2] and the 2023 [1] imaging data is that in the latter [1], the increase in probe uptake (given as SUV, standardized uptake value) is now seen in the lymph nodes, gut (and many other regions of the body, the latter a feature that points to a non-specific nature of the biodistribution) at later cycles of the LRA administration, when also the heart (blood pool) probe uptake is increasing, which is happening in all animals at the later cycles of [1]. As described by mathematicians in the 80’s, when changes in input function take place, the use of the SUV to quantitate changes in probe uptake could be misleading and requires mathematical modeling of the time activity curves generated in serial imaging along with an input function [7], or at least a normalization on the blood pool (heart).

      This phenomenon of the increase in heart uptake (which indicates blood pool) following Galunisertib administration was not noted in the animals of the [2] publication. Only in one animal of the previous 2022 publication, the authors claimed increase in the radiotracer uptake of the heart. However, the figures and videos associated to this particular animal (A14X004) reveal a potentially important inconsistency, as described under note-*3.2.

      It would be helpful, in general, to standardize measurements of covariates generated in different labs, especially in studies that are closely related to each other like the [1] and [2] studies. Note under note-*4 lack of standardization in measurements of CAVL viral RNA and CAVL viral DNA between [2] and [1] studies.

      Notes and Bibliography

      note-*1. Figure 3H of [2] shows that the highest increases in lymph node (LN) uptake are in monkeys A14X060, A14X064, and A14X013. In these animals, PET images show clear evidence of significant extravasation of the injected probe into the subcutaneous tissues ipsilateral to the high LN uptake. A fourth animal (A14X027) has a slight increase in LN uptake with smaller extravasation. The four animals above are 4 of the 5 animals that the authors claim in the Abstract of [2] show increase in probe uptakes in lymph nodes caused by the administration of the LRA. It is well known, however, that when radiolabeled antibodies\fragments are intentionally or unintentionally (infiltration) administered by subcutaneous or intradermal route, they find their way into the lymphatics and then non-specifically concentrate in regional draining nodes [8], as it appears to be the case for the animals listed above since the radiotracer uptake in LNs was much higher on the side of infiltration than the contralateral side or than in distant nodes. For this reason, the SUV analysis should not have included those LNs in Figure 3H. Without those LNs, however, it looks like from the published images that there is no increase in probe uptake in the LNs, as claimed in the abstract of [2] in which a causal link between Galunisertib administration and increase in LNs in probe uptake is inferred from the data analysis.<br /> Video1…8 from the JCI-I link<br /> Video 1 (A14x027, suv-scale=1.5) : https://insight.jci.org/art...<br /> Video 2 (A14x037, suv-scale=1.5): https://insight.jci.org/art...<br /> Video 3 (A14x060, suv-scale=1.5): https://insight.jci.org/art...<br /> Video 4 (A14x064, suv-scale=1.5): https://insight.jci.org/art...<br /> Video 5 (A14x004, suv-0.3, kidney and liver removed) : https://insight.jci.org/art...<br /> Video 6 (A14xX005, suv-scale=1.5): https://insight.jci.org/art...<br /> Video 7 (A14x013, suv-scale=1.5): https://insight.jci.org/art...<br /> Video 8 (A14x004, suv-scale=1.5): https://insight.jci.org/art...

      note-*2. In Samer et al. [2] we read “The 64Cu-DOTA-F(ab′)2 p7D3 was previously validated in SIV-uninfected macaques (62)”, with ref 62 being ref [3] of this document. In the pre-print Kim et al. for the characterization of the probe the Samer et al. [2] reference is provided. <br /> However, in ref [3] only the intact 64Cu-DOTA-7D3 and not the F(ab’)2 was tested in vitro in data presented in Suppl Figure S1 of [3]. In particular, Suppl Fig S1C of [3] shows approximately 2-fold only difference in radiotracer uptake in a competition assay using gp120 expressing cell lines, that are known to express gp120 at much higher levels than primary cells (e.g. pbmc, spleen or lymph node cells). Of note, the competition assay of S1C shows rapid loss in binding when the radiotracer is incubated with only 25% more of the non-radiolabeled (cold) ligand, which is unexpected for high affinity binding ligands. <br /> All these four imaging NHP studies [1-4], produced by the same imaging team, lack autoradiography analyses. The latter ex-vivo technique generates powerful data for the in vivo inference, as typically done in oncological pre-clinical research, because, as mathematicians have shown when they first attempted to extract quantitative information from the PET images [7], what the in vivo imaging is revealing is not a signal proportional to the absolute concentration of the target, but rather a signal that is proportional to the binding capacity of the probe, which is the product of the probe affinity times the concentration of the target. The implication is that if the latter is very low, we can have in our hands a very high affinity ligand, yet we will not be able to generate an SUV level that is predominantly explained by specific binding of the probe. In absence of autoradiography data, some evidence of binding capacity can be generated by implementing in vitro cell binding assays using primary cells (e.g. PBMC or splenocytes or lymph node cells from infected animals and compare the binding to same cells from uninfected animals). This was done only in the first publication [3] in Nature Methods, in which a two-fold (only) difference in SUV uptake was observed by comparing uninfected and infected spleen and lymph node cells (S1B) ex vivo incubated with the radiotracer. <br /> However, the binding data were generated using cryopreserved cells without cold-competition assays; the latter would be useful to rule out, for instance, putative higher non-specific uptake due to higher cell death in the infected cells following their thawing. In general, it would be helpful to increase the sample size of S1B of the 2015 publication [3] (for instance only one well for uninfected lymph node cells were used for that piece of data, which precludes any robust conclusion from the data), as well as to produce autoradiography studies, as mentioned above, in which tissue sections are incubated with close to kd concentration of the probe and after washing, the tissue sections uptakes are compared to the non-specific uptake generated by pre-incubating the adjacent tissue sections with large amount of the cold (i.e, non-radiolabeled) probe to block all gp120 receptors in the tissue sections.

      Additional validations of the observed increased SUV uptakes in SIV infected animals, or following the administration of an LRA, as claimed in the 4 NHP publications, is particularly warranted given the state-of-art research in this area and given that, because of the high costs and demanding resources associated to these studies, few laboratories in the world have the capacity of reproducing these experimental data.

      note-*3.1 The study [2] did not appear to exclude in the analysis of the gut areas that are consistent with the intraluminal antibody excretion in bowel segments, because details of how the gut SUV uptake was obtained were missing from the Methods section of the [2] publication. The new [1] pre-print states “To quantify the signal in the gut tissue, the body segment below the stomach to above the cervix was initially isolated. The Gut’s SUV was then calculated by extracting the spleen, both kidneys, liver, and bones within the designated body region using Boolean operations.” The latter approach , if adopted also in the [2] publication with those high levels of gut SUV probe uptake seen soon after cycle 1 in some of the animals, again proves that those areas are consistent with the intraluminal antibody excretion (e.g. stools) in bowel segments were not excluded in the analysis, however, this is not what is commonly done in antibody imaging studies [5], because it is known that this phenomenon of non specific uptake in the gut due to the excretion of these types of radiotracers can occur.

      note-*3.2 Figure 3F in [2] is a figure obtained from Supplemental Video 5 (https://insight.jci.org/art... ), with baseline and post-LRA images displayed with SUV-rainbow-scale = 0.3 for animal A14X004. Based on the legends, all other animals are displayed at SUV-scale =1.5. (baseline is before LRA (i.e first panel to the left) and middle and right panels are images at week 1 post LRA for one week and week 2 post-LRA for another week, respectively). <br /> Based on the legends, and consistent with the CT anatomy of the Video 5, the Video 8 https://insight.jci.org/art... shows the same images, before subtracting liver and kidney, displayed at 1.5 SUV. If we try to picture how the Video 8 (baseline, left panel) would look like by putting our hand on top of the liver and kidney to mask these two organs, it appears that what is left is an image that is the same image displayed in Video 5 (first panel to the left) or Figure 3F (first panel to the left). However, the legends state that the scales are different for Video5\Fig3F (0-0.3) and Video 8 (0-1.5), hence also the colors of the baseline images of Video 5 and 8 should be the different.<br /> In other words, Video 8 and Figure3F\Video 5 are incompatible. The evidence that Video 5 and Video 8 of reference [2] require to be harmonized for the validity of the whole dataset, can be also deduced by looking at the rainbow scale of the images. The rainbow scale goes from black to blue to green to yellow to red. So if we fix it to max SUV=1.5, it means that if an SUV uptake is 1.5 or higher, it will show up as red, and all the other colors would indicate levels below SUV=1.5 …for instance green is around 0.7. Now, if the rainbow is fixed to max Suv=0.3, it means that whatever is 0.3 or higher will be red, and green is in the middle, around 0.15. If Figure 3F\Video 5 is correct but the mistake was done in Video 8 (left panel was set at SUV scale 0.3 instead of 1.5 like written in the legends), then once displayed on a scale 1.5, the left panel of Video 8 should show a liver and kidney in color bluish...(which is not seen in the liver and kidney of any other animals, hence the latter scenario would point to a very fast biodistribution of the probe, which is consistent with a damage of the probe). <br /> Two different versions of the Samer et al. paper can be found online, the PMC version and the JCI-Insight version, which differ primarily on the biodistribution of the A14X004 (video 5 and video 8).

      Some of the differences between JCI-Insight link (https://insight.jci.org/art... current version online modified in June 2023) and the PMC-link (dated November 2022 https://www.ncbi.nlm.nih.go... ) are here outlined:

      A)<br /> JCI-I: However, a probe generated using a rhesus IgG1 Fab against an irrelevant antigen 64Cu-DOTA-F(ab′)2 pIgG1 in an SIV-infected macaque was used as further control (Supplemental Figure 8 and Supplemental Video 9). <br /> PMC: However, a probe generated using a rhesus IgG1 Fab against an irrelevant antigen 64Cu-DOTA-F(ab′)2 pIgG1 in an SIV-infected macaque was used as further control (Supplemental Figure 8 and Supplemental Video 2). <br /> Note, Suppl video 2 in PMC link shows images of A14X037, hence unrelated to the sentence above in the PMC link.<br /> B)<br /> JCI-I: A smaller increase in the gut was also present in A14X004 and A14X060 (Figure 3G, Supplemental Video 5, and Supplemental Video 8).<br /> PMC: A smaller increase in the gut was also present in A14X004 and A14X060 (Figure 3G, Supplemental Video 5, and Supplemental Figure 1). <br /> In this case too, Supplemental Figure 1 in PMC link shows figure title TGF-β inhibits HIV-1 latency reactivation by PMA in ACH-2 cells, hence unrelated to sentence in the PMC link.<br /> Consistent with the changes above, the supplemental materials in PMC do not show Supplemental Video 8 and Video 9. The videos legend, however, is the same on both links, i.e. points to the existence of additional two videos (called movie S1 and movie S2) in both the PMC and JCI-I links. None of the two links however call movie S1 or movie S2 in the main text, so this is an editing mistake probably propagated for 3 corrections made on the JCI-Insight publication, the last one dated June 14th 2023 based on the Version History section linked to the publication https://insight.jci.org/art... .

      C) Video 1 link of the PMC link does not contain the animal ID listed in the legend, but animal A14x004 displayed at 0-1.5 SUV scale (what became Video 8 in the JCI-I link)<br /> D) the PMC link date is Nov 2022, the JCI-I link shows that changes were made in June 2023 based on the third upload of the supplementary material file.

      note-*4. Figure S3 from the [1] pre-print shows CAVL-RNA in the gut with unit measurement [copies/ml] and ranges 0-30; in the 2022 [2] paper Fig 4A shows the same covariate but with unit measurement [copies/10to6] cell-eq and ranges (0.1-1,000) log-scale; <br /> Figure S4A from the [1] pre-print show CAVL-DNA in different organs with unit measurement [log copies/10to4 cell-eq, range 0-5]…; in the 2022 [2] paper Fig 4C shows the same covariate but with unit measurement [copies/10to 6] y-axis transformation unclear;

      1. Kim, J., TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo. 2023.<br /> https://www.biorxiv.org/con...

      2. Samer, S., et al., Blockade of TGF-beta signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo. JCI Insight, 2022. 7(21).<br /> https://insight.jci.org/art...

      3. Santangelo, P.J., et al., Whole-body immunoPET reveals active SIV dynamics in viremic and antiretroviral therapy-treated macaques. Nat Methods, 2015. 12(5): p. 427-32.<br /> https://pubmed.ncbi.nlm.nih...

      4. Santangelo, P.J., et al., Early treatment of SIV+ macaques with an alpha(4)beta(7) mAb alters virus distribution and preserves CD4(+) T cells in later stages of infection. Mucosal Immunol, 2018. 11(3): p. 932-946.<br /> https://www.ncbi.nlm.nih.go...

      5. Beckford-Vera, D.R., et al., First-in-human immunoPET imaging of HIV-1 infection using (89)Zr-labeled VRC01 broadly neutralizing antibody. Nat Commun, 2022. 13(1): p. 1219.<br /> https://pubmed.ncbi.nlm.nih...

      6. Hnatowich, D.J., et al., Pharmacokinetics of the FO23C5 anti-CEA antibody fragment labelled with 99Tcm and 111In: a comparison in patients. Nucl Med Commun, 1993. 14(1): p. 52-63.

      7. Mintun, M.A., et al., A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol, 1984. 15(3): p. 217-27.

      8. Keenan, A.M., et al., Immunolymphoscintigraphy and the dose dependence of 111In-labeled T101 monoclonal antibody in patients with cutaneous T-cell lymphoma. Cancer Res, 1987. 47(22): p. 6093-9.<br /> https://pubmed.ncbi.nlm.nih...

    1. On 2023-09-29 01:11:11, user Kevin Corbett wrote:

      Xibing, Thanks for the reminder and my apologies for not citing this important paper! We'll be sure to cite it in the revised version and the final published version. - Kevin

    2. On 2023-09-27 09:22:07, user xibing wrote:

      Hi, <br /> Really nice work on Ubl systems from bacteria. Just a kind reminder, ThiS-ThiF ubl-E1/2 of E. coli could attach ubl to some substrates in vivo and in vitro, please check doi: 10.1016/j.ijbiomac.2019.08.172.<br /> Best wishes,<br /> Xibing

    1. On 2023-09-28 21:27:59, user LabTerra wrote:

      Dear authors,

      First and foremost, we would like to congratulate you on your work. The text is relevant given the context of climate change and despite the inherent complexity of this subject and the extensive analysis conducted, you effectively guided the discussion in a clear and compelling manner. We also found the research idea and the results obtained to be quite intriguing, showing how different climate variables influence beta diversity and its components. In particular, the taxonomic diversity being more aligned with phylogenetic and functional diversity in the tropics as opposed to temperate and polar regions, is a very interesting finding.

      That being said, we believe that some of the results could have been further explored in the discussion section and that the introduction could use additional information to highlight the work's importance and clarify some of the choices made, such as more details on why the LGM was chosen for comparison.

      Below, we provide a list of specific suggestions that we hope could contribute to your work, especially for the clarification of some of the results and methods used and for a more comprehensive discussion section.

      List of specific comments:

      The importance of your work and how it relates to current climate change could be further emphasized in the introduction section.<br /> It is mentioned that precipitation seasonality was the main variable explaining total beta-diversity. This result could be better explored in the discussion, as it was only briefly mentioned in the results section.<br /> Consider integrating some of the limitations identified in the methodology section in the discussion as well. For example, the explanation on how the gaps in the functional traits dataset could affect your results.<br /> As it is mentioned in the discussion section, the climate changes that are happening now are different from the changes that happened in the last glaciation. We believe the comparisons made between them and the conclusions reached could be expressed with less certainty.<br /> While the importance of conserving a network of protected areas in regions with rare species is indicated in the discussion section, this subject could have received more attention. It's also worth emphasizing in the text that such actions will likely not be enough to stop climate change-driven extinctions on their own.<br /> The high beta-diversity in regions such the Sahara transition and the USA is an intriguing result that could be investigated.<br /> In the models, the r² values are high for the combined variables, but relatively low for individual variables. The study focuses on the effects of the LGM anomaly, but we believe that a more in-depth exploration of the interactions among the studied variables would be beneficial.<br /> We found it unclear what corresponds to a “species” (used in taxonomic diversity) in the context of phylogenetic and functional diversity. Do these correspond to functional and phylogenetic groups?<br /> Figure 1a caption is somewhat confusing, as it mentions beta diversity but only shows LGM anomaly.<br /> In figures 2 and 4, we recommend that all sub-figures share a consistent scale to facilitate comparisons between them.<br /> Figures 2 (j, k and l) and 4 could use a different color scale. Light yellow is especially difficult to discern from the background white.<br /> The inclusion of a table with the description of all environmental variables used to compare with beta-diversity might be beneficial to the understanding of the reader.

      We hope that our suggestions will help in further improving the quality of your work.

      Kind regards,

      The LabTerra team

    1. On 2023-09-28 15:29:05, user Lennart Wirthmueller wrote:

      The proteomics data described in this preprint are now available in the PRIDE database with the following identifiers.

      Dataset S1 - PXD045780

      Dataset S2 - PXD045511, PXD045544, PXD045545

      Dataset S3 - PXD045638, PXD045558, PXD045548

      Dataset S4 - PXD045726

      Dataset S5 - PXD045549

      Dataset S6 - PXD045550

    1. On 2023-09-27 16:50:48, user Vanessa Staggemeier wrote:

      This study is very interesting, the authors provide a perspective on the conservation status of all angiosperms. The topic is timely, and the manuscript brings a useful tool to build a fast evaluation of the extinction risk for species that have not yet been assessed by the IUCN.

      The high number of species without conservation status assessment (~82% of all vascular plants) was a big surprise to us, taking this number into account we believe the proposed tool can help to advance in the classification of conservation status. Predictions of extinction risk could help to prioritise assessment efforts for species predicted with high certainty to be threatened and also for species with uncertain predictions, which could be triaged as Data Deficient and prioritised for further fieldwork.

      We enjoyed reading this manuscript very much, but we have some questions that were raised during a lab meeting planned to discuss this preprint, which we leave below.

      1) We know that many new species described in recent years are listed as threatened in the description, however this information is not included in the IUCN Red List. So, our question is, why is this information not reaching the IUCN, what alternatives could be applied to overcome this issue?

      2) We saw that it is available a more recent data on the Human Footprint, which is Sanderson et al. but it is a preprint article (https://doi.org/10.32942/os..., why was this reference not used?

      3) In 2017 was published an update on ecoregions, we saw that the changes from Olson et al. 2001 are few, but why did you choose to work with the oldest instead of Dinerstein et al. (2017)?<br /> Dinerstein, E., Olson, D., Joshi, A., Vynne, C., Burgess, N. D., Wikramanayake, E., ... & Saleem, M. (2017). An ecoregion-based approach to protecting half the terrestrial realm. BioScience, 67(6), 534-545.

      We also leave some suggestions to the authors:<br /> 1) It would be interesting to map the results by biome (the results were shown by botanical country, Fig. 2). It is our belief that the species in the botanical country of Northeastern Brazil are from the Atlantic Forest (AF) and not from the Caatinga because the level of degradation is higher in the AF and there are also many more studies in the AF than in the Caatinga. This map would be of more interest to researchers working on specific biomes.

      2) We think it would be useful to provide a list with the classification (conservation status predictions) and degree of uncertainty for each species.

      3) Some tables in the Supplementary Information that are .csv files (e.g. Table S3) are not accessible … or we do not know how to access them.

      Congratulations to all the authors, this paper is an excellent contribution, providing predictions of conservation status for each species, which can provide a basis from which full Red List assessments can progress more quickly.

      Comment written at a meeting of the Laboratório de Ecologia Vegetal, Evolução e Síntese (LEVES) at the Universidade Federal do Rio Grande do Norte, RN, Brasil. Joined this meeting: Vanessa Staggemeier, Hercília Freitas, Víctor de Paiva, Cassia Oliveira, Rhuama Martins and João Paulo Câmara.

    1. On 2023-09-26 03:19:45, user MichaelNeville wrote:

      Where can we listen to soil eco-acoustics? We teach healthy, living soils through composting, worm farming and mulching. being able to listen would be a fantastic teaching tool.

    1. On 2023-09-25 16:32:21, user Leonardo Couto wrote:

      Dear Authors,

      I am Leonardo Couto, a master's student at the Federal University of Minas Gerais (UFMG), located in Belo Horizonte, Minas Gerais, Brazil. I am currently being supervised by Professor Juliane Karine Ishida. Throughout my academic career, I have been studying the interaction between plants and microorganisms, and your preprint titled "Disease Resistance correlates with Core Microbiome Diversity in Cotton" caught my attention. Recently, our research group received an invitation to evaluate preprints in order to gain experience and contribute to the advancement of science. Therefore, I have chosen your work for discussion in one of our meetings. In collaboration with other colleagues, we have brought forth some suggestions to assist in improving your article, and we hope they may prove useful to you.<br /> We noticed a lack of introductory content in his introduction, which would be essential to better understand his study.<br /> (Lines 95-100) - The explanation of cotton leaf roll disease (CLCuD) and its economic implications for the country is provided only at the conclusion of the preprint. We believe these topics could be explored in more depth in your introduction.<br /> We also note that the text is not structured into categories such as introduction, methodology, results, and conclusion. We understand that this may be in line with the journal's guidelines.<br /> In your methodology section (lines 62 - 68), we missed a more detailed description of your samples. For example, we are curious about the distribution of samples among susceptible, partially tolerant, and fully tolerant varieties. Furthermore, it would be useful to know how many samples are attributed to epiphytic leaves, endophytic leaves, rhizosphere, and endophytic roots. We suggest that compiling this data into a supplementary table could be beneficial.<br /> These are some small contributions we offer to help you further improve and refine your work. We hope these suggestions are valuable to you in advancing your research.

      Yours sincerely,

      Leonardo Couto<br /> Master's Student, Federal University of Minas Gerais (UFMG)

    1. On 2023-09-25 13:25:38, user Lander De Coninck wrote:

      Hi,

      Great manuscript! I completely agree that we need to sequence more individual mosquitoes, if we ever want to understand the complex relationships between insect-specific viruses, arboviruses and their hosts.

      However, I have one big remark that I hope you consider to change in the published version of this manuscript. On line 175, you mention 393 mosquito-associated viruses and you define them as the 'core mosquito virome' for the rest of the manuscript. I feel that this term is too broad to describe just all your mosquito-associated viruses (some of them might be found in only one or very few individual mosquitoes). In general, a core microbiome can be defined as a set of taxa that consistently occur within a given habitat type or host (see https://journals.asm.org/doi/10.1128/msystems.01066-22 and https://www.pnas.org/doi/full/10.1073/pnas.2104429118). Also, Shi et al. (Microbiome, 2019), one of the first papers to describe a core virome in mosquitoes, describes the core mosquito virome as "a set of viruses found in the majority of individuals in a particular mosquito population".

      Could you change the use of this term in your manuscript to avoid confusion for readers and have a consistent use of the term "core virome" in future research?

      Kind regards,

      Lander

    1. On 2023-09-24 20:09:58, user Prof. T. K. Wood wrote:

      This work fails to cite our work, which has been used by 40 labs since 2013, to create an uniform population of persister cells through chemical pretreatment (doi:10.1128/AAC.02135-12) and instead indicates incorrectly, “one challenge in mechanistic research on persisters is the enrichment of pure persisters.” Also, this work fails to cite the only mechanistic model for persistence: ribosome dimerization (doi.org/10.1016/j.bbrc.2020...:vvLQGhdcuqrN__QUPD2ivE3-d5g "doi.org/10.1016/j.bbrc.2020.01.102)") and fails to cite the first single cell works on persister resuscitation (doi:10.1111/1462-2920.14093 & doi.org/10.1016/j.isci.2019...:N5cNvOkLn_Ksn053qV3G6Ofwii0 "doi.org/10.1016/j.isci.2019.100792)"). It also fails to recognize the perils of PI staining (not all non-red cells are viable, doi:10.1111/1462-2920.14075).

    1. On 2023-09-23 22:43:21, user masfique@gmail.com wrote:

      I missed responding to your comment. It is a nuclear localization signal (NLS). The experimental evidence confers the existance of a functional NLS at the predicted protease site.

    1. On 2023-09-22 23:48:41, user Duncan Muir wrote:

      Summary:<br /> Arrhenius/Eyring behavior for enzymes (i.e., a linear increase in kcat with temperature) is predicted by transition state theory. Nevertheless, deviations from this minimal model have been observed over the years[4]. Work from groups including Klinmman[27,28] and Daniel and Danson[21] have exemplified this unexpected, non-Arrhenius behavior of enzymes and have sought to apply models to these observations, including an equilibrium between active and inactive states of the substrate-bound enzyme[21]. Åqvist and colleagues [5] have sought to distinguish between competing models, including the activation heat capacity model from this manuscript, and the equilibrium model. In the literature, there are contradictory reports regarding the role of activation heat capacity [22,8], leaving the debate on the origin of non-linear temperature dependence of activity unresolved.

      This paper aims to characterize conformational changes during catalysis through the lens of activation heat capacity. The authors used MalL as a model system and conducted kinetics experiments over a range of temperatures to calculate changes in the heat capacity of activation. Using molecular dynamics, the authors simulate a narrowed conformational landscape of a transition state-like MalL in comparison to wild-type. Based on the observed kinetic behavior of MalL across a wide range of temperatures, the authors presented MMRT-2S, a modified version of Macromolecular Rate Theory (MMRT) that accounts for a cooperative transition between the enzyme-substrate conformation and the transition state-like conformation. The major strength of this paper is high quality temperature-dependent kinetic data collected over a range of temperatures typically not explored, which allows us to evaluate complex models to describe unexpected enzymatic behavior. The major confusion we have with this paper is the lack of details needed to aid the reader in interpreting the data: namely not presenting the hydrogen bond measurements and statistics to demonstrate significance, and a lack of controls or citations for kinetic assay assumptions. Overall, this paper presents an intriguing explanation for the role of conformational changes in catalysis to reconcile diverse observations noted in enzyme literature.

      Major points:<br /> Substrate Saturation, Denaturation Controls, and Assay Set-UpAccording to the methods section, saturating concentrations of p-nitrophenyl-α-D-glucopyranoside were assayed. It would be helpful if exact concentrations were reported for reproducibility of the work. Furthermore, it is important to mention if Km has been reported at the range of temperatures assayed for this substrate, to confirm saturation.

      The text mentions that nonlinearity has been reported in this absence of denaturation; this statement could be strengthened if controls or references were included to corroborate this.

      From the description in the methods section, we believe the enzyme is not incubated at the assay temperature prior to the reaction, so over the course of the limited reaction time (45 seconds) we are unsure if the enzyme has reached a folded/conformational equilibrium. Furthermore, we think it would be informative for readers if the authors include discussion about foldedness being unlikely to be a contributor to changes in kcat.

      Mutant Structure RationaleThe rationale for creating the S536R mutant is unclear to us. Although we agree that “introducing new hydrogen bond networks at the surface of the protein” is one way to perturb conformational dynamics and rates, we are unsure why arginine was selected as the residue for this. We are also unsure why the X-ray structures were determined in the presence of urea.

      Mutant / TLC ActivityThe mutant structure shows a distinct ensemble via the PCA projection. It is important to discuss if activity data collected for this mutant should be expectedly different from WT based on the MMRT-2S model.

      Hydrogen Bond MeasurementGiven the difference in crystal packing between the wild-type and mutant structures, it is important to identify if any of the hydrogen bonds of interest are proximal to a gained or lost crystal contact between the two structures.<br /> Additionally, while truncating the data to a similar resolution will remove high resolution reflections from the mutant structure, the reflections around 2.3Å will likely have higher signal:noise, which complicates analysis. <br /> It would be helpful for readers to have more details on the hydrogen bonds mentioned in Figure 5A – for example, by creating a table of the residues involved in each bond and the amount that the bond was shortened. Further interpretation of the shortened hydrogen bonds would also be helpful; for example, we are curious if the authors consider all the shortened hydrogen bonds as equal contributors to the restricted conformational landscape of the TLC, or if there are certain ones that the authors believe are more impactful.

      Additionally, for those unfamiliar with MD, more commentary on the interplay between structural data and MD simulations would be instructive. For example, are residue motions observed in MD simulations consistent with the hydrogen bonding differences observed in the static structure?

      ADH ComparisonWe are unsure if the authors’ claims contrasting MalL and ADH at different temperatures are supported by the data, given that there was no MD performed on ADH. For MalL, we were able to visualize the restricted conformational landscape of the TLC via a combination of MD simulations and structural data. For ADH, only Cp is calculated from kinetics data, and there is no structure or MD data presented. Arguing that there is a more restricted conformational landscape based on Cp alone seems insufficient compared to the amount of work done on MalL. Perhaps citing more previous literature on ADH in detail would be helpful for strengthening the contrast between MalL and ADH.

      Minor points:<br /> Language / Word Choice:Use of word “significant” should be reserved for demonstrated statistical significance<br /> Qualifiers like “very” were used frequently and distract from the data and claims in themselves, particularly in section headers i.e., “Very High Resolution Structure...”<br /> “Accurate” should be replaced with “precise” when describing collected data, as the data themselves are observations of ground truth, and the narrow distribution of replicates implies high precision

      Scope<br /> The claim “The importance of activation heat capacity for enzyme kinetics has been the subject of debate recently” is supported by 3 self-references, out of four total.

      In previous work, the authors identify that MMRT applies to chemically-limited catalysis, which should be mentioned in the discussion regarding the applicability of the model, and cite Kern and Hilser’s works on adenylate kinase as an edge case as in the author’s previous reviews.

      Figures <br /> In general, the addition of more labels/legends on the plots would help with interpretation.<br /> Specific examples:<br /> Figure 2: labeling the color that corresponds to each mutant <br /> Figure 3: labeling deuterated vs protiated <br /> Figure 3D: labeling which curves correspond to ∆H and ∆S<br /> Figures 4A & 4B: For clarity, the different regions of MalL (lid, active site, loop, etc.) could be labeled here. Furthermore, arrows depicting the motions observed in PCA1 and PCA2 would be informative.<br /> Figure 5A: For clarity, the S536R mutation could be labeled here.

      • Daphne Chen, Duncan Muir, Margaux Pinney, Jaime Fraser
    1. On 2023-09-22 10:19:46, user Adrian Newman-Tancredi wrote:

      Dear authors, <br /> Congratulations on this very interesting study with a large amount of data. We indeed agree that targeting 5-HT1A receptors is a promising strategy for addressing pain conditions, among others. Concerning your comment in the Introduction that "adverse side effects led to termination of clinical trials" for befiradol, please note that trials were, in fact, terminated for lack of efficacy in the chosen pain indication, not because of AEs (see https://www.clinicaltrialsr.... Please note that befiradol has successfully undergone clinical testing for treatment of Parkinson's disease with an excellent safety and tolerability profile (see https://www.einnews.com/pr_.... I would be grateful if you can send me a pdf of the accepted publication in due course. <br /> Best regards,<br /> Adrian Newman-Tancredi

    1. On 2023-09-21 10:57:45, user Diego di Bernardo wrote:

      Very interesting result. We just published in Hepatology a study of the drug sensitivity of the C2 subtype (i.e. Embryonal in this manuscript) and one of our top computational prediction was Brivanib an unspecific FGFR inhibitor, well in agreement with the findings of this manuscript. Also we found CDK9 inhibitors as effective. To know more here is the link: https://journals.lww.com/he...

    1. On 2023-09-21 08:56:51, user John Meadows wrote:

      This is a detailed version of a paper presented at the Radiocarbon conference in Zurich in September 2022. The manuscript was submitted to a prominent multidisciplinary journal in February 2023, and sent for peer review. One review was returned quickly, but the journal failed to obtain a second review, despite replacing the handling editor. After waiting over 6 months, we withdrew the manuscript from this journal and submitted a slightly revised version to another journal, while simultaneously posting this pre-print.

    1. On 2023-09-20 19:29:22, user Colin Reardon wrote:

      Interesting paper. The dataset reference for this study does not seem to be correct. "GSE227331" is an accession number for "METTL3-mediated m6A modification controls splicing factor abundance and contributes to CLL progression"

    1. On 2023-09-20 14:35:36, user Damien Gregoire wrote:

      Happy to make our results available to the scientific community. We are welcoming feedbacks on the manuscript, comments and questions. DG

    1. On 2023-09-20 08:03:53, user Ramon Crehuet wrote:

      I think this paper provides a new perspective on biomolecular LLPS. I have a very specific issue about figure 5. The (e) case is a limiting case of (c) with X_HO tending to 0. But (d) and (f) are completely different. In one case the slope is negative and in the other it is positive? Could it be that the components have been exchanged?

    1. On 2023-09-19 19:05:27, user S. An wrote:

      This article is now published:<br /> Danielle L. Schmitt, Patricia Dranchak, Prakash Parajuli, Dvir Blivis, Ty Voss, Casey L. Kohnhorst, Minjoung Kyoung, James Inglese, and Songon An* "High-throughput screening identifies cell cycle-associated signaling cascades that regulate a multienzyme glucosome assembly in human cells” PLoS One (2023) 18, e0289707

    1. On 2023-09-19 18:56:14, user Lloyd Fricker wrote:

      Confirmation of results is an essential part of science. Our original finding that the peptide PEN is an agonist of GPR83 was already verified by two different laboratories (see Foster et al, 2019, “Discovery of Human Signaling Systems: Pairing Peptides to G Protein-Coupled Receptors”, Cell, PMID: 31675498; and Parobchak et al, 2020,<br /> “Uterine Gpr83 mRNA is highly expressed during early pregnancy and GPR83 mediates the actions of PEN in endometrial and non-endometrial cells”, FS Science, PMID: 35559741). However, when another laboratory can’t confirm what was published, it is important to consider differences between the studies. With this in mind, there are several issues with the study presented here in the BioRxiv report by Giesecke et al. Additional experiments described below would be very helpful.

      The HEK293 cell line has been reported to express GPR83 mRNA in many studies listed in GEO Profile, and this is confirmed in the current study (Figure 1A). In the figure showing overexpression of HA-tagged GPR83 in HEK293 cells, the distribution is largely intracellular, maybe ER or Golgi (Figure 1B). Thus, it’s not relevant to consider ‘100-fold’ overexpression based on mRNA, as the amount that is correctly folded and expressed at the cell surface may not be much different than in the native HEK293 cell line. Furthermore, the authors show that PEN peptide does produce a robust increase in phosphoERK in Figure 4A (compare the lanes labeled ‘control’ and ‘PEN’). Furthermore, it looks like the PEN-mediated increase in phosphoERK is several fold higher in GPR83-transfected cells than in control cells (Figure 4A). Although the quantitation panel in Figure 4B doesn’t show an increase, there are very large ‘error bars’ reported to be SD, but for N=2 doesn’t SD really mean the range of duplicates? Also, please show all data points in the bar graph! In any case, it would be nice to see a larger N for these studies. But best of all would be a knock-down of GPR83 in HEK293 cells using siRNA, or a related approach.

      Another point is that in the PEN-GPR83 peptide-receptor system, signaling assays that are distal to the receptor activity (cAMP, PLC) tend to give variable results – this has been previously noted in our original study (Gomes et al, PMID: 27117253). This also appears to be the case with the TANGO assay where we have recently found that long-term treatment with PEN (16 hrs) causes a desensitization of the receptor leading to a complete loss of signal (our unpublished observations). There are also issues with the concentration dependence, and ‘u-shaped’ curves where high concentrations of PEN fail to produce the effects seen with lower concentrations (PMID: 27117253). The authors should repeat the studies with shorter times and lower concentrations of PEN.

      The lack of binding with Tyr-PEN seen by Giesecke et al. could be due to the presence of an internal His residue in human PEN (YAADHDVGSELPPEGVLGALLRV). Tyr-PEN used in our previous studies for iodination was the rat sequence, which does not have a His. Because His residues can be iodinated using the chloramine T procedure used by Giesecke et al, this can potentially affect binding. It would be good to test binding with iodinated rat Tyr-PEN, to avoid the His residue. Also, why the C-term amide group? That’s not part of PEN.

      For the Ca++ assays, Giesecke et al. used Gα16, but our previous studies used Gα16/i3 (PMID: 27117253). This is not a minor difference. Ideally, Giesecke et al could repeat the experiments with Gα16/i3.

      Finally, protease inhibitors were used in the binding studies by Giesecke et al, which is good. It is not clear if such inhibitors were used in all other studies with PEN, such as those described in Figure 2 and 3. In the absence of protease inhibitors, PEN could be degraded during the assays and this could have accounted for the negative results.

      Sincerely,<br /> Ivone Gomes,<br /> Lloyd Fricker,<br /> Lakshmi Devi

    1. On 2023-09-19 14:25:20, user Courtier wrote:

      The part entitled "The recombinant common ancestors became more similar to SARS-CoV-1 and SARS-CoV-2 with increased sampling" should be done on sampling dates rather than publication dates. If the authors want to analyse publication dates, that is fine, but they should also show the same analysis with sampling dates, which to me is more relevant than publication dates.

      For the phylogenetic analysis, it seems that the authors did not take into account the sampling date of each virus. It would be nice to check whether the branch lengths estimated by their phylogenetic models are compatible with the sampling dates.

      Fig. 2: it would be nice to show in a supplementary table the names of the viruses shown as blue diamonds in Fig. 2.

    1. On 2023-09-19 13:19:44, user Ema Nymton wrote:

      A few comments:<br /> Figure 1 essentially estimates the tMRCA of lineage A and B from 3xB and 1xA sequences. The resulting confidence interval is of course, massive. It is not surprising that it overlaps with other estimates that essentially also estimate the tMRCA of A and B. I fail to see how this adds anything new or supports any conclusion.

      Figure 2's use of p-values does not properly account for the extreme sampling bias: sampling intensity around the wildlife stalls was much higher than elsewhere. More sampling leads to better p-values. Tom Wenseleers' analysis here is more proper: https://twitter.com/TWensel...<br /> Figure 2 B is particularly vulnerable to this bias, as the sequencing attempts were extremely clustered.<br /> Figure 2C seems to have omitted some data points: compare with this from Tom Wenseleers again: https://twitter.com/TWensel...<br /> Overall, the data actually points to an area near the market entrance/the toilets/the mah jong rooms, and the "hot areas" are not over the wildlife stalls.

      The sampling bias is also particularly visible in figure 3B, which would seem to show an association of human reads with wildlife stalls, when of course, the presence of humans was fairly uniform throughout the market (likely higher concentrations around the entrance/toilets/bathrooms)

      Figure 4 is notable because it shows CoVs definitively associated with wildlife had a significantly different distribution than SARS-CoV-2. Either SARS-CoV-2 did not emerge from those wilflife stalls, or too much time had passed to make any conclusions. It also serves as evidence against their argument that SARS-CoV-2 RNA from infected animals would have decayed substantially (as the other CoV RNA apparently had not).

      Figure 5 is interesting, but it does not establish where any of the animals came from. It simply rules out Vietnam and a Chinese provine north of Hubei. The authors then proceed to engage in pure speculation about the possibility of the Raccoon dogs coming from an area known to have SARS-CoV-2 like viruses.

      Overall, I see nothing new here, just more analysis of very biased and hopelessly impoverished data

    2. On 2023-09-17 03:50:07, user David Bahry wrote:

      1. There is a likely citation-typo on pp. 10-11. The authors write,

      Prior studies calculated correlations of SARS-CoV-2 detection and animal sequence read abundances in market samples, concluding that SARS-CoV-2 was negatively correlated with mammalian wildlife species (Liu et al. 2023; Bloom 2021).

      The intended citation is presumably to (Bloom 2023), not to (Bloom 2021).

      1. The authors claim that "The start of the COVID-19 pandemic was traced epidemiologically to the Huanan Wholesale Seafood Market" (p. 3). This is false or misleading.

      After the first-detected market-linked cluster was noticed, this led the search for more cases to focus heavily on the market: i.e., that is simply where the local Chinese authorities looked, as they have made clear in repeated statements (Bahry 2023, Table 1). For instance, the WHO-China joint study emphasizes the "epidemiology surveillance at several hospitals (close to Huanan market), Huanan market and the neighbourhood of Huanan market" (WHO-China 2021, Annex p. 125).

      Strangely, the authors do not cite these repeated warnings about sampling bias in the early search, by those who did the search. Nor do they cite my critique (Bahry 2023) of their earlier attempt to control for such bias (Worobey et al. 2022).

      1. Strangely, the authors' heat map in their "relative risk" analysis of positivity rate (Fig. 2a) shows very little heat for the highest-positivity-rate stall: a beef stall in the east wing with 1/1 samples positive (cf. Bahry 2023, Fig. 1). Although the authors do not explain this anomaly, it seems to be due to an analytical strategy which downplays less-sampled stalls. Their heat map does not depict stalls' positivity rates: rather it depicts the p-values of stalls' positivity rates. However, smaller samples will automatically have lower p-values for the same positivity rate, due to smaller samples having lower power to detect the same effect size.

      Thus, rather than showing the spatial distribution of elevated positivity, their heat map more reflects the spatial distribution of sampling effort (heavily concentrated in the southwest wildlife corner).

      An alternative approach would have been to map relative risk itself, estimated with smoothing by pseudocounts (cf. Bahry 2023, Fig. 1). Estimating positivity as s+0.077/n+1, for s positives out of n samples, takes into account both the 7.7% positivity base rate, and noise due to uncertainty in less-sampled stalls.

    1. On 2023-09-18 17:43:46, user J Wallace wrote:

      I'm sorry, what new does this actually add? These "laws" appear to just be fundamental properties of DNA as known for literally decades. Please explain how this actually adds new knowledge to the field.

    1. On 2023-09-17 06:30:29, user Diego del Alamo wrote:

      This is a comment on version 1 of this manuscript.

      The authors present compelling evidence that fine-tuning sequence-based machine learning models (protein language models) on in-house experimental data can accelerate the discovery of high-affinity binders, in this case against CD40. However, the entire manuscript is focused on single-chain nanobodies, not antibodies as the text suggests, and the authors only mention this in second and third paragraphs of Results as well as the caption of Figure 2.

      This is an extremely important distinction and I think the authors need to revise their language throughout the document to make this clear; i.e., use the term nanobody, not antibody. Nanobodies differ from antibodies in several key respects, such as loop lengths, which are discussed here: doi.org/10.3389/fimmu.2023..... Relevant to this manuscript is the fact that they comprise a single chain, and are thus amenable to out-of-the-box masked and/or autoregressive protein language models. Standard antibodies consist of two chains; to my knowledge, only one method, which has not been peer reviewed, has been trained on paired antibody sequences: arxiv.org/abs/2308.14300. Thus, several obstacles still exist that prevent the methods described here from being directly translated to standard monoclonal antibodies. The manuscript does not discuss or acknowledge these obstacles.